# Obsessive-compulsive disorder in the World Mental Health surveys.

<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Med</journal-id><journal-id journal-id-type="iso-abbrev">BMC Med</journal-id><journal-title-group><journal-title>BMC Medicine</journal-title></journal-title-group><issn pub-type="epub">1741-7015</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmcid">12239380</article-id><article-id pub-id-type="pmid">40629326</article-id>
<article-id pub-id-type="publisher-id">4209</article-id><article-id pub-id-type="doi">10.1186/s12916-025-04209-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Obsessive-compulsive disorder in the World Mental Health surveys</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Stein</surname><given-names>Dan J.</given-names></name><address><email>dan.stein@uct.ac.za</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Ruscio</surname><given-names>Ayelet Meron</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Altwaijri</surname><given-names>Yasmin</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Chiu</surname><given-names>Wai Tat</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Sampson</surname><given-names>Nancy A.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Aguilar-Gaxiola</surname><given-names>Sergio</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Al-Hamzawi</surname><given-names>Ali</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Alonso</surname><given-names>Jordi</given-names></name><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Chardoul</surname><given-names>Stephanie</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Gureje</surname><given-names>Oye</given-names></name><xref ref-type="aff" rid="Aff11">11</xref><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Chiyi</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name><surname>Karam</surname><given-names>Elie G.</given-names></name><xref ref-type="aff" rid="Aff14">14</xref><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><name><surname>McGrath</surname><given-names>John J.</given-names></name><xref ref-type="aff" rid="Aff16">16</xref><xref ref-type="aff" rid="Aff17">17</xref><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name><surname>Navarro-Mateu</surname><given-names>Fernando</given-names></name><xref ref-type="aff" rid="Aff19">19</xref><xref ref-type="aff" rid="Aff20">20</xref><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Scott</surname><given-names>Kate M.</given-names></name><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author"><name><surname>Stagnaro</surname><given-names>Juan Carlos</given-names></name><xref ref-type="aff" rid="Aff23">23</xref></contrib><contrib contrib-type="author"><name><surname>Torres</surname><given-names>Yolanda</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name><surname>Vladescu</surname><given-names>Cristian</given-names></name><xref ref-type="aff" rid="Aff25">25</xref><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Wci&#x000f3;rka</surname><given-names>Jacek</given-names></name><xref ref-type="aff" rid="Aff27">27</xref></contrib><contrib contrib-type="author"><name><surname>Xavier</surname><given-names>Miguel</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name><surname>Kessler</surname><given-names>Ronald C.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><collab>the World Mental Health Survey collaborators<contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Stein</surname><given-names>Dan J.</given-names></name><address><email>dan.stein@uct.ac.za</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Aguilar-Gaxiola</surname><given-names>Sergio</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Al-Hamzawi</surname><given-names>Ali</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Alonso</surname><given-names>Jordi</given-names></name><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Chardoul</surname><given-names>Stephanie</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Gureje</surname><given-names>Oye</given-names></name><xref ref-type="aff" rid="Aff11">11</xref><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Karam</surname><given-names>Elie G.</given-names></name><xref ref-type="aff" rid="Aff14">14</xref><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><name><surname>McGrath</surname><given-names>John J.</given-names></name><xref ref-type="aff" rid="Aff16">16</xref><xref ref-type="aff" rid="Aff17">17</xref><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name><surname>Navarro-Mateu</surname><given-names>Fernando</given-names></name><xref ref-type="aff" rid="Aff19">19</xref><xref ref-type="aff" rid="Aff20">20</xref><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Scott</surname><given-names>Kate M.</given-names></name><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author"><name><surname>Stagnaro</surname><given-names>Juan Carlos</given-names></name><xref ref-type="aff" rid="Aff23">23</xref></contrib><contrib contrib-type="author"><name><surname>Vladescu</surname><given-names>Cristian</given-names></name><xref ref-type="aff" rid="Aff25">25</xref><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Xavier</surname><given-names>Miguel</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name><surname>Kessler</surname><given-names>Ronald C.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Altwaijri</surname><given-names>Yasmin A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Andrade</surname><given-names>Laura Helena</given-names></name></contrib><contrib contrib-type="author"><name><surname>Atwoli</surname><given-names>Lukoye</given-names></name></contrib><contrib contrib-type="author"><name><surname>Benjet</surname><given-names>Corina</given-names></name></contrib><contrib contrib-type="author"><name><surname>Borges</surname><given-names>Guilherme</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bruffaerts</surname><given-names>Ronny</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bunting</surname><given-names>Brendan</given-names></name></contrib><contrib contrib-type="author"><name><surname>Caldas-de-Almeida</surname><given-names>Jose Miguel</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cardoso</surname><given-names>Gra&#x000e7;a</given-names></name></contrib><contrib contrib-type="author"><name><surname>Degenhardt</surname><given-names>Louisa</given-names></name></contrib><contrib contrib-type="author"><name><surname>de Girolamo</surname><given-names>Giovanni</given-names></name></contrib><contrib contrib-type="author"><name><surname>Haro</surname><given-names>Josep Maria</given-names></name></contrib><contrib contrib-type="author"><name><surname>Harris</surname><given-names>Meredith G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hinkov</surname><given-names>Hristo</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Chiyi</given-names></name></contrib><contrib contrib-type="author"><name><surname>de Jonge</surname><given-names>Peter</given-names></name></contrib><contrib contrib-type="author"><name><surname>Karam</surname><given-names>Aimee Nasser</given-names></name></contrib><contrib contrib-type="author"><name><surname>Karam</surname><given-names>Georges</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kazdin</surname><given-names>Alan E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kawakami</surname><given-names>Norito</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kiejna</surname><given-names>Andrzej</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kovess-Masfety</surname><given-names>Viviane</given-names></name></contrib><contrib contrib-type="author"><name><surname>Medina-Mora</surname><given-names>Maria Elena</given-names></name></contrib><contrib contrib-type="author"><name><surname>Moskalewicz</surname><given-names>Jacek</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nishi</surname><given-names>Daisuke</given-names></name></contrib><contrib contrib-type="author"><name><surname>Piazza</surname><given-names>Marina</given-names></name></contrib><contrib contrib-type="author"><name><surname>Posada-Villa</surname><given-names>Jos&#x000e9;</given-names></name></contrib><contrib contrib-type="author"><name><surname>Roest</surname><given-names>Annelieke</given-names></name></contrib><contrib contrib-type="author"><name><surname>ten Have</surname><given-names>Margreet</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tintle</surname><given-names>Nathan</given-names></name></contrib><contrib contrib-type="author"><name><surname>Viana</surname><given-names>Maria Carmen</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vigo</surname><given-names>Daniel V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Williams</surname><given-names>David R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wojtyniak</surname><given-names>Bogdan</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zaslavsky</surname><given-names>Alan M.</given-names></name></contrib></contrib-group></collab></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03p74gp79</institution-id><institution-id institution-id-type="GRID">grid.7836.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 1151</institution-id><institution>SAMRC Unit On Risk &#x00026; Resilience in Mental Disorders, Dept of Psychiatry &#x00026; Neuroscience Institute, </institution><institution>University of Cape Town, </institution></institution-wrap>Cape Town, South Africa </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00b30xv10</institution-id><institution-id institution-id-type="GRID">grid.25879.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8972</institution-id><institution>Department of Psychology, </institution><institution>University of Pennsylvania, </institution></institution-wrap>Philadelphia, PA USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05n0wgt02</institution-id><institution-id institution-id-type="GRID">grid.415310.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2191 4301</institution-id><institution>Biostatistics, Epidemiology and Scientific Computing Department, </institution><institution>King Faisal Specialist Hospital &#x00026; Research Center, </institution></institution-wrap>Riyadh, Saudi Arabia </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03vek6s52</institution-id><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Health Care Policy, </institution><institution>Harvard Medical School, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05q8kyc69</institution-id><institution-id institution-id-type="GRID">grid.416958.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0413 7653</institution-id><institution>Department of Internal Medicine, Center for Reducing Health Disparities, </institution><institution>UC Davis Health System, </institution></institution-wrap>Sacramento, CA USA </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02ewzwr87</institution-id><institution-id institution-id-type="GRID">grid.440842.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 7474 9217</institution-id><institution>College of Medicine, </institution><institution>University of Al-Qadisiya, </institution></institution-wrap>Al Diwaniyah, Diwaniya Governorate Iraq </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03a8gac78</institution-id><institution-id institution-id-type="GRID">grid.411142.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1767 8811</institution-id><institution>Health Services Research Unit, Hospital del Mar Medical Research Institute (IMIM), </institution></institution-wrap>Barcelona, Spain </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04n0g0b29</institution-id><institution-id institution-id-type="GRID">grid.5612.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2172 2676</institution-id><institution>Department of Medicine and Life Sciences, </institution><institution>Pompeu Fabra University (UPF), </institution></institution-wrap>Barcelona, Spain </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/050q0kv47</institution-id><institution-id institution-id-type="GRID">grid.466571.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 1756 6246</institution-id><institution>Centro de Investigaci&#x000f3;n Biom&#x000e9;dica en Red de Epidemiolog&#x000ed;a y Salud P&#x000fa;blica (CIBERESP), </institution></institution-wrap>Madrid, Spain </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00jmfr291</institution-id><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7347</institution-id><institution>Survey Research Center, </institution><institution>Institute for Social Research, University of Michigan, </institution></institution-wrap>Ann Arbor, MI USA </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/022yvqh08</institution-id><institution-id institution-id-type="GRID">grid.412438.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 1764 5403</institution-id><institution>Department of Psychiatry, </institution><institution>University College Hospital, </institution></institution-wrap>Ibadan, Nigeria </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05bk57929</institution-id><institution-id institution-id-type="GRID">grid.11956.3a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2214 904X</institution-id><institution>Department of Psychiatry, </institution><institution>Stellenbosch University, </institution></institution-wrap>Cape Town, South Africa </aff><aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02skpkw64</institution-id><institution-id institution-id-type="GRID">grid.452897.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 6091 8446</institution-id><institution>Shenzhen Institute of Mental Health &#x00026; Shenzhen Kangning Hospital, </institution></institution-wrap>Shenzhen, China </aff><aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04q71jj82</institution-id><institution-id institution-id-type="GRID">grid.429040.b</institution-id><institution>Institute for Development, Research, Advocacy and Applied Care (IDRAAC), </institution></institution-wrap>ResearchBeirut, Lebanon </aff><aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04bagh120</institution-id><institution-id institution-id-type="GRID">grid.416659.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1773 3761</institution-id><institution>Department of Psychiatry and Clinical Psychology, </institution><institution>St George Hospital University Medical Center, </institution></institution-wrap>Beirut, Lebanon </aff><aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/017zhda45</institution-id><institution-id institution-id-type="GRID">grid.466965.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 0624 0996</institution-id><institution>Queensland Centre for Mental Health Research, The Park Centre for Mental Health, </institution></institution-wrap>Wacol, QLD Australia </aff><aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00rqy9422</institution-id><institution-id institution-id-type="GRID">grid.1003.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9320 7537</institution-id><institution>Queensland Brain Institute, </institution><institution>The University of Queensland, </institution></institution-wrap>St Lucia, QLD Australia </aff><aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01aj84f44</institution-id><institution-id institution-id-type="GRID">grid.7048.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 1956 2722</institution-id><institution>National Centre for Register-Based Research, Aarhus University, </institution></institution-wrap>Aarhus, Denmark </aff><aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/055bn0x53</institution-id><institution-id institution-id-type="GRID">grid.419058.1</institution-id><institution-id institution-id-type="ISNI">0000 0000 8745 438X</institution-id><institution>Unidad de Docencia, Investigacion y Formaci&#x000f3;n en Salud Mental (UDIF-SM), Servicio Murciano de Salud, Murcia Health Service, </institution></institution-wrap>C/Lorca, n&#x000ba; 58. - El Palmar, Murcia, 30120 Spain </aff><aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/058thx797</institution-id><institution-id institution-id-type="GRID">grid.411372.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 0534 3000</institution-id><institution>Instituto Murciano de Investigaci&#x000f3;n Biosanitaria - Pascual Parrilla (IMIB-Pascual Parrilla), Hospital Virgen de la Arrixaca, </institution></institution-wrap>El Palmar, Murcia, 30120 Spain </aff><aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/050q0kv47</institution-id><institution-id institution-id-type="GRID">grid.466571.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 1756 6246</institution-id><institution>Centro de Investigaci&#x000f3;n Biom&#x000e9;dica en ERed en Epidem&#x000ed;ologia y Salud P&#x000fa;blica (CIBERESP), </institution></institution-wrap>Madrid, 28029 Spain </aff><aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01jmxt844</institution-id><institution-id institution-id-type="GRID">grid.29980.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7830</institution-id><institution>Department of Psychological Medicine, </institution><institution>University of Otago, </institution></institution-wrap>Dunedin, Otago New Zealand </aff><aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0081fs513</institution-id><institution-id institution-id-type="GRID">grid.7345.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 0056 1981</institution-id><institution>Departamento de Psiquiatr&#x000ed;a y Salud Mental, Facultad de Medicina, </institution><institution>Universidad de Buenos Aires, </institution></institution-wrap>Buenos Aires, Argentina </aff><aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/037p13h95</institution-id><institution-id institution-id-type="GRID">grid.411140.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 0812 5789</institution-id><institution>Center for Excellence On Research in Mental Health, </institution><institution>CES University, </institution></institution-wrap>Medell&#x000ed;n, Colombia </aff><aff id="Aff25"><label>25</label>National Institute for Health Services Management, Bucharest, Romania </aff><aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0367qb939</institution-id><institution-id institution-id-type="GRID">grid.445737.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 0480 9237</institution-id><institution>University Titu Maiorescu, </institution></institution-wrap>Bucharest, Romania </aff><aff id="Aff27"><label>27</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0468k6j36</institution-id><institution-id institution-id-type="GRID">grid.418955.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2237 2890</institution-id><institution>Department of Psychiatry, </institution><institution>Institute of Psychiatry and Neurology, </institution></institution-wrap>Warsaw, Poland </aff><aff id="Aff28"><label>28</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01c27hj86</institution-id><institution-id institution-id-type="GRID">grid.9983.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2181 4263</institution-id><institution>Nova Medical School, </institution><institution>Nova University of Lisbon, </institution></institution-wrap>Lisbon, Portugal </aff></contrib-group><pub-date pub-type="epub"><day>9</day><month>7</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>9</day><month>7</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>23</volume><elocation-id>416</elocation-id><history><date date-type="received"><day>23</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>11</day><month>6</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">National surveys have suggested that obsessive-compulsive disorder (OCD) is a prevalent and impairing condition. However, there are few cross-national data on OCD, with data particularly scarce in low- and middle-income countries. Here we employ data from the World Mental Health surveys to characterize the onset, course, severity, and treatment of OCD across a range of countries in different geographic regions of the world.</p></sec><sec><title>Methods</title><p id="Par2">Data came from general population surveys carried out in 10 countries (Argentina, Australia, Colombia, Iraq, Poland, People&#x02019;s Republic of China, Portugal, Romania, Saudi Arabia, Spain) using a consistent research protocol and interview. A total of 26,136 adults were assessed for OCD in face-to-face interviews and were included in the present analyses. We examined lifetime and 12-month prevalence as well as age of onset, persistence, severity, and treatment of <italic>DSM-IV</italic> OCD in six high-income countries (HICs) and four low- or middle-income countries (LMICs). We also investigated socio-demographic variables and temporally prior mental disorders as predictors of OCD onset, persistence, severity, and treatment.</p></sec><sec><title>Results</title><p id="Par3">Across the 10 countries surveyed, OCD has a combined lifetime prevalence of 4.1%. The 12-month prevalence (3.0%) is nearly as high, suggesting a highly persistent course of illness. Age of onset is early, with more than 80% of OCD cases beginning by early adulthood. Most OCD cases in the community are mild (47.0%) or very mild (27.5%), with a smaller percentage designated as moderate (22.9%) or severe (2.7%) by the Yale-Brown Obsessive-Compulsive Scale. Only 19.8% of respondents with OCD received any mental health treatment in the past year, with treatment rates much higher in HICs (40.5%) than LMICs (7.0%). Cross-nationally, OCD commonly emerges in adolescence or early adulthood against a backdrop of earlier-occurring mental disorders. With few exceptions (e.g., prior social phobia), the socio-demographic and psychopathological risk factors for OCD onset, persistence, severity, and treatment are distinct.</p></sec><sec><title>Conclusions</title><p id="Par4">These cross-national data underscore clinical lessons regarding the importance of early diagnosis of OCD and comprehensive evaluation of comorbidity; draw attention to OCD as an undertreated disorder, particularly in LMIC contexts; and emphasize the public health significance of this often-overlooked condition.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12916-025-04209-5.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Obsessive-compulsive disorder</kwd><kwd>Community epidemiology</kwd><kwd>Global mental health</kwd><kwd>World Mental Health surveys</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001322</institution-id><institution>South African Medical Research Council</institution></institution-wrap></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100019223</institution-id><institution>Ministry of Health &#x02013; Kingdom of Saudi Arabia</institution></institution-wrap></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Center for Excellence on Research in Mental Health (CES University)</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Ministry of Health Iraq</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Shenzhen Bureau of Health</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Australian Government Department of Health and Ageing</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Regional Health Authorities of Murcia</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Argentinian Ministry of Health</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Polish Ministry of Health</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Champalimaud Foundation</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000025</institution-id><institution>National Institute of Mental Health</institution></institution-wrap></funding-source><award-id>R01 MH070884</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par22">Obsessive-compulsive disorder (OCD) was traditionally considered a relatively rare condition in the general population and in mental health clinics [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. Advances in psychiatric epidemiology, including the use of structured interviews based on <italic>Diagnostic and Statistical Manual of Mental Disorders</italic> (<italic>DSM</italic>) diagnostic criteria, overturned this view. In the 1980s, the Epidemiological Catchment Area (ECA) survey in the USA used the Diagnostic Interview Schedule (DIS) to assess <italic>DSM-III</italic> OCD and found a lifetime prevalence of 2.3% [<xref ref-type="bibr" rid="CR3">3</xref>]. Surveys employing this instrument in six other high-income countries indicated that most lifetime prevalence rates fell within the range of 1.9% (in Korea) to 2.5% (in Puerto Rico) [<xref ref-type="bibr" rid="CR4">4</xref>].
</p><p id="Par23">The World Health Organization Composite International Diagnostic Interview (CIDI) incorporated additional advances, including the use of dimensional symptom severity measures [<xref ref-type="bibr" rid="CR5">5</xref>]. Employing the CIDI, the National Comorbidity Survey Replication (NCS-R) in the USA found a lifetime prevalence of 2.3% for <italic>DSM-IV</italic> OCD, while also observing a high prevalence of subthreshold OCD symptoms in the population [<xref ref-type="bibr" rid="CR6">6</xref>]. Additional key findings were that OCD typically emerges against a backdrop of temporally prior mental disorders and that the severity of OCD is robustly associated with role impairment, with severe OCD cases reporting more severe disability in occupational and social domains, and substantially more days out of role, than moderate cases [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par24">Despite these advances, several aspects of the epidemiology of OCD require further attention [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. First, there are very few representative surveys in non-Western countries&#x02014;especially in low- and middle-income countries, where the large majority of the world&#x02019;s population resides [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Surveys of this sort are needed given well-documented limitations of generalizing behavioral research findings from Western, Educated, Industrialized, Rich, and Democratic (WEIRD) societies to other parts of the world [<xref ref-type="bibr" rid="CR9">9</xref>]. Second, with the exception of early work using the DIS, there has been a dearth of cross-national research on the epidemiology of OCD. In fact, no cross-national study has used the improved <italic>DSM-IV</italic> diagnostic criteria [<xref ref-type="bibr" rid="CR10">10</xref>], which were largely unchanged in <italic>DSM-5</italic> [<xref ref-type="bibr" rid="CR11">11</xref>]. Investigating OCD across cultures provides an opportunity to identify more universal features and correlates of the disorder than can be observed when studying individual cultures [<xref ref-type="bibr" rid="CR12">12</xref>]. It also capitalizes on the larger sample sizes&#x02014;and corresponding statistical power&#x02014;afforded by aggregating OCD cases across surveys. Third, while there has been some research on correlates of OCD onset in the community [<xref ref-type="bibr" rid="CR7">7</xref>], little epidemiological research has considered correlates of other important outcomes, such as OCD persistence, severity, and treatment. Moreover, with the exception of the NCS-R [<xref ref-type="bibr" rid="CR6">6</xref>], past research has focused on cross-sectional associations between correlates and OCD. This has made it difficult to determine which correlates precede the onset of OCD and consequently reflect risk factors for OCD-related outcomes [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par25">The World Mental Health (WMH) surveys, the world&#x02019;s largest set of coordinated community surveys of mental disorders [<xref ref-type="bibr" rid="CR14">14</xref>], allow detailed investigation of the epidemiology of OCD. Here we employed data from the WMH surveys to characterize the onset, course, severity, and treatment of OCD across a range of high-income and low- and middle-income countries in different geographic regions of the world. Then, using an aggregated cross-national dataset, we evaluated temporally prior variables, including socio-demographic characteristics and earlier mental disorders, as predictors of subsequent OCD-related outcomes.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Sample</title><p id="Par26">Data came from single-interview WMH surveys administered between 2005 and 2019 in 10 countries (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Six of the surveys were administered in countries classified by the World Bank as high-income (HICs) at the time of data collection; they included nationally representative surveys in Argentina, Australia, Poland, Portugal, and Saudi Arabia, as well as a regional survey in Murcia, Spain. Four of the surveys were administered in countries classified by the World Bank as low- or middle-income (LMICs); they included nationally representative surveys in Iraq and Romania, as well as regional surveys in Medellin, Colombia and Shenzhen, People&#x02019;s Republic of China. The combined sample size across surveys was <italic>N</italic>&#x02009;=&#x02009;26,136. All respondents were age 18 or older at the time of the survey.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Prevalence of <italic>DSM-IV</italic> OCD in the World Mental Health surveys</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Country</th><th align="left" colspan="2">Lifetime prevalence</th><th align="left" colspan="2">12-month prevalence</th><th align="left" colspan="2">12-month prevalence among lifetime cases</th><th align="left"/></tr><tr><th align="left">%</th><th align="left">(SE)</th><th align="left">%</th><th align="left">(SE)</th><th align="left">%</th><th align="left">(SE)</th><th align="left">(<italic>n</italic>)</th></tr></thead><tbody><tr><td align="left">I. Low- or middle-income countries (LMIC)</td><td align="left">4.9</td><td align="left">(0.3)</td><td align="left">3.9</td><td align="left">(0.3)</td><td align="left">80.3</td><td align="left">(2.1)</td><td align="left">(12,567)</td></tr><tr><td align="left">&#x02003;Medellin, Colombia</td><td align="left">2.8</td><td align="left">(0.8)</td><td align="left">2.4</td><td align="left">(0.8)</td><td align="left">85.3</td><td align="left">(6.7)</td><td align="left">(541)</td></tr><tr><td align="left">&#x02003;Iraq</td><td align="left">4.6</td><td align="left">(0.5)</td><td align="left">3.6</td><td align="left">(0.4)</td><td align="left">79.7</td><td align="left">(5.1)</td><td align="left">(4,332)</td></tr><tr><td align="left">&#x02003;Shenzhen, People&#x02019;s Republic of China</td><td align="left">5.5</td><td align="left">(0.4)</td><td align="left">4.5</td><td align="left">(0.4)</td><td align="left">80.4</td><td align="left">(2.1)</td><td align="left">(7,132)</td></tr><tr><td align="left">&#x02003;Romania</td><td align="left">0.6</td><td align="left">(0.3)</td><td align="left">0.5</td><td align="left">(0.3)</td><td align="left">82.0</td><td align="left">(12.5)</td><td align="left">(562)</td></tr><tr><td align="left">II. High-income countries (HIC)</td><td align="left">3.4</td><td align="left">(0.2)</td><td align="left">2.2</td><td align="left">(0.1)</td><td align="left">65.9</td><td align="left">(3.3)</td><td align="left">(13,569)</td></tr><tr><td align="left">&#x02003;Argentina</td><td align="left">2.9</td><td align="left">(0.8)</td><td align="left">2.5</td><td align="left">(0.8)</td><td align="left">86.3</td><td align="left">(7.5)</td><td align="left">(692)</td></tr><tr><td align="left">&#x02003;Australia</td><td align="left">3.7</td><td align="left">(0.3)</td><td align="left">2.6</td><td align="left">(0.2)</td><td align="left">70.7</td><td align="left">(4.2)</td><td align="left">(8,463)</td></tr><tr><td align="left">&#x02003;Poland</td><td align="left">1.3</td><td align="left">(0.4)</td><td align="left">0.3</td><td align="left">(0.1)</td><td align="left">23.1</td><td align="left">(9.6)</td><td align="left">(1,607)</td></tr><tr><td align="left">&#x02003;Portugal</td><td align="left">5.3</td><td align="left">(1.1)</td><td align="left">4.4</td><td align="left">(0.9)</td><td align="left">82.4</td><td align="left">(7.7)</td><td align="left">(539)</td></tr><tr><td align="left">&#x02003;Saudi Arabia</td><td align="left">4.0</td><td align="left">(0.7)</td><td align="left">1.8</td><td align="left">(0.4)</td><td align="left">45.1</td><td align="left">(7.2)</td><td align="left">(1,789)</td></tr><tr><td align="left">&#x02003;Murcia, Spain</td><td align="left">0.4</td><td align="left">(0.3)</td><td align="left">0.3</td><td align="left">(0.2)</td><td align="left">70.7</td><td align="left">(17.1)</td><td align="left">(479)</td></tr><tr><td align="left">III. Total sample</td><td align="left">4.1</td><td align="left">(0.2)</td><td align="left">3.0</td><td align="left">(0.1)</td><td align="left">74.1</td><td align="left">(1.9)</td><td align="left">(26,136)</td></tr></tbody></table><table-wrap-foot><p><italic>Abbreviations</italic>
<italic>OCD</italic> obsessive-compulsive disorder, <italic>SE</italic> standard error</p></table-wrap-foot></table-wrap></p><p id="Par27">All surveys used multistage clustered area probability household sample designs. Response rates for individual surveys ranged from 60.0 to 97.2%, with a weighted (by sample size) average response rate across surveys of 70.9% (Additional File 1 Appendix Table&#x000a0;1). Interviews were conducted face-to-face in respondents&#x02019; homes. Other than in Australia, Iraq, and Romania, the interview was divided into two parts. Part 1 assessed core disorders (as detailed below in the section on Comorbid Disorders) and was administered to all respondents. Part 2 addressed additional disorders, including OCD, and correlates, and was administered to all Part 1 respondents who met criteria for any lifetime Part 1 disorder plus a probability subsample of other respondents. The reason for this division is that, as most respondents do not have a history of mental disorder, interviewing all non-cases in full is unnecessary to maximize statistical power for case-control comparisons. Significant efficiencies can therefore be achieved by ending the interview early for a random subsample of non-cases once it is determined that they do not meet criteria for any mental disorder [<xref ref-type="bibr" rid="CR15">15</xref>]. Part 1 data were weighted to adjust for differential probabilities of selection and to match population distributions on Census socio-demographic and geographic distributions. Part 2 data were additionally weighted for the undersampling of Part 1 respondents without core disorders.</p></sec><sec id="Sec4"><title>Measures</title><sec id="Sec5"><title>Interview</title><p id="Par28">Trained lay interviewers administered a fully structured diagnostic interview, the World Health Organization Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) [<xref ref-type="bibr" rid="CR5">5</xref>]. The interview and training materials were developed in English and subsequently translated into other languages using a comprehensive protocol designed to achieve both conceptual equivalence and measurement consistency across countries. High-quality translations were obtained through a structured six-step process: (1) forward translation; (2) expert panel review; (3) independent back-translation; (4) harmonization of terminology and phrasing across countries sharing the same language; (5) pretesting with cognitive interviewing; and (6) final revision, production, and documentation of the translated instrument [<xref ref-type="bibr" rid="CR16">16</xref>]. Interviewers were required to complete a standardized training course successfully before they could undertake fieldwork and collect data for the study. Consistent procedures were then used across surveys to check interviewer accuracy and implement standardized data cleaning and coding procedures [<xref ref-type="bibr" rid="CR17">17</xref>]. Informed consent was obtained before starting the interview. Local institutional review committees approved and monitored the surveys to ensure protection of human subjects per international and local guidelines. All procedures contributing to this work complied with the ethical standards of the relevant national and institutional committees on human experimentation.</p></sec><sec id="Sec6"><title>OCD diagnosis, onset, persistence, and severity</title><p id="Par29">OCD was assessed using an updated version of CIDI 3.0 that improved the skip logic of the OCD section to conform more closely to <italic>DSM-IV</italic> diagnostic criteria than earlier CIDI versions. All countries that administered this improved OCD section were included in the present analyses. The OCD section assessed lifetime experiences of contamination, harming, ordering, hoarding, and &#x0201c;other&#x0201d; obsessions and compulsions (O/C). Respondents endorsing one or more of the O/C types were asked about time spent on obsessions (described as <italic>repeated unpleasant thoughts</italic>,<italic> images</italic>,<italic> or impulses</italic>) and compulsions (described as <italic>behaviors people feel driven to do over and over, either physically or in their mind</italic>). Subsequent questions assessed any reported obsessions for all other diagnostic criteria of OCD, followed by a parallel series of questions for any reported compulsions. <italic>DSM-IV</italic> general medical and substance-related exclusions, but not diagnostic hierarchy rules, were applied in making diagnoses. Respondents who met <italic>DSM-IV</italic> criteria for OCD in their lifetime were asked about their age when they first had significant obsessions or compulsions that either took up at least 1 h per day, caused distress, or interfered with their day-to-day activities, as well as their age when they most recently experienced obsessions or compulsions most days for at least 2&#x000a0;weeks. Persistence was defined as the proportion of respondents with lifetime OCD who qualified for the disorder in the past 12&#x000a0;months. A clinical reappraisal study carried out with a subset of NCS-R respondents [<xref ref-type="bibr" rid="CR6">6</xref>] showed that CIDI OCD diagnoses had excellent individual-level concordance with diagnoses assigned by clinical interviewers using the Structured Clinical Interview for <italic>DSM-IV</italic> (SCID) [<xref ref-type="bibr" rid="CR18">18</xref>], with an area under the receiver operating characteristic curve of 0.95 and a kappa of 0.90 (<italic>SE</italic>&#x02009;=&#x02009;0.03). Sensitivity was 90.2, specificity was 99.7, and total classification accuracy was 99.5.</p><p id="Par30">Clinical severity of 12-month OCD cases was assessed using a fully structured version of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) (question wording can be found at [<xref ref-type="bibr" rid="CR19">19</xref>]). The Y-BOCS is the clinical standard for assessing the severity of OCD [<xref ref-type="bibr" rid="CR20">20</xref>]. As several respondents reported either obsessions without compulsions or compulsions without obsessions and consequently were administered only half of the Y-BOCS, we calculated severity scores for all respondents by taking the higher of the Y-BOCS obsessions and compulsions subscale scores, then doubling this score to arrive at the standard Y-BOCS metric familiar to researchers and clinicians. This approach, previously employed in the NCS-R [<xref ref-type="bibr" rid="CR6">6</xref>], is supported by work showing that with good clinical probing obsessions and compulsions almost always co-exist, and that severity scores on the Y-BOCS obsessions and compulsions subscales tend to be similar [<xref ref-type="bibr" rid="CR10">10</xref>]. Different severity cut points have been proposed for the Y-BOCS. To capture OCD cases across the full severity continuum, we adopted an approach that includes very mild scores (0&#x02013;7) as well as scores for mild (8&#x02013;15), moderate (16&#x02013;24), and severe (24&#x02013;31) symptoms [<xref ref-type="bibr" rid="CR21">21</xref>].</p></sec><sec id="Sec7"><title>Comorbid disorders</title><p id="Par31">CIDI 3.0 assesses lifetime and 12-month mental disorders using <italic>DSM-IV</italic> diagnostic criteria. Blinded clinical reappraisal studies carried out in Asia [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>], Europe [<xref ref-type="bibr" rid="CR24">24</xref>], Latin America [<xref ref-type="bibr" rid="CR25">25</xref>], the Middle East [<xref ref-type="bibr" rid="CR26">26</xref>], and the USA [<xref ref-type="bibr" rid="CR27">27</xref>] have found consistently good concordance between diagnoses based on the CIDI and diagnoses based on blinded gold-standard clinical interviews using the SCID.</p><p id="Par32">We analyzed all disorders that were assessed by at least nine of the 10 countries in the current report. Aside from OCD, this included four anxiety disorders (panic disorder with or without agoraphobia, social phobia, generalized anxiety disorder, posttraumatic stress disorder), two mood disorders (major depressive disorder and bipolar spectrum disorder, the latter of which included bipolar I disorder, bipolar II disorder, and subthreshold bipolar disorder), two substance use disorders (alcohol and drug use disorders, each of which included abuse and dependence), and one externalizing disorder (attention-deficit/hyperactivity disorder; ADHD). Respondents meeting lifetime criteria for any disorder were asked about age of onset using a question series designed to facilitate accurate dating [<xref ref-type="bibr" rid="CR28">28</xref>]; responses were used to determine the temporal order of each disorder vis-&#x000e0;-vis OCD.</p></sec><sec id="Sec8"><title>Socio-demographic characteristics</title><p id="Par33">Several socio-demographic variables were examined as predictors of OCD. They included the respondent&#x02019;s <italic>sex</italic> (male/female) and <italic>age at interview</italic> (divided into categories of 18&#x02013;29&#x000a0;years, 30&#x02013;44&#x000a0;years, 45&#x02013;59&#x000a0;years, and 60+&#x02009;years). They also included other variables defined in relation to the age of onset of OCD. <italic>Age of onset</italic> was a continuous variable representing the respondent&#x02019;s age when OCD began, whereas <italic>time since onset</italic> represented the number of years between age of onset and age at interview. <italic>Education</italic> was categorized by years of matriculation completed before OCD onset: low (0&#x02013;6&#x000a0;years), low&#x02010;average (7&#x02013;9&#x000a0;years), high&#x02010;average (10&#x02013;15&#x000a0;years), and high (16+&#x02009;years), with a separate category included for respondents who were enrolled as a student when OCD began. <italic>Marital status</italic> at OCD onset included categories of never married, married, or previously married, with the latter category including respondents who were separated, divorced, or widowed.</p></sec><sec id="Sec9"><title>Treatment</title><p id="Par34">Twelve-month treatment estimates were obtained by asking respondents if they received treatment for any mental or behavioral problem in the past year. Summary measures of 12-month treatment were created separately for services received in the <italic>health care</italic> sector (further subdivided into <italic>general medical</italic> and <italic>mental health specialty</italic>) and the <italic>non-health care</italic> sector (further subdivided into <italic>human services</italic> and <italic>complementary-alternative medicine</italic>), as well as for services received in <italic>any</italic> sector in the year before the interview.</p></sec></sec><sec id="Sec10"><title>Statistical analysis</title><p id="Par35">Weights were applied to the data to adjust for differences in within-household probabilities of selection and to calibrate the samples to match Census population distributions on socio-demographic and geographic variables. Part 2 data were also weighted to adjust for differential probabilities of selection into Part 2. The Taylor series linearization method, implemented in SAS 9.4 [<xref ref-type="bibr" rid="CR29">29</xref>], was used to adjust standard errors for the effects of these weights as well as for the effects of geographic clustering of the WMH data.</p><p id="Par36">Cross-tabulations were used to estimate the prevalence, persistence, and severity of OCD, and to examine treatment seeking as a function of severity. Age-of-onset distributions were estimated separately for males and females with OCD using the actuarial method. Discrete-time survival analysis with person-year as the unit of analysis [<xref ref-type="bibr" rid="CR30">30</xref>] was used to predict lifetime OCD. Each survival model tested whether the respondent&#x02019;s status on a given socio-demographic variable or comorbid disorder in the year before OCD onset was associated with the first onset of OCD the following year, controlling for all other variables in the model. By contrast, person-level logistic regression analysis was used to predict 12-month OCD outcomes, including persistence, severity, and treatment. These person-level models examined whether the respondent&#x02019;s status on a given socio-demographic variable or comorbid disorder at the time that OCD began was associated with OCD-related outcomes in the year before interview. The temporal order of OCD and other variables was determined from retrospective age-of-onset reports. Survival coefficients were transformed to odds ratios (ORs) with 95% confidence intervals (CIs) for ease of interpretation. Statistical significance was evaluated at the 0.05 level using two-sided tests.</p></sec></sec><sec id="Sec11"><title>Results</title><sec id="Sec12"><title>Prevalence</title><p id="Par37">Across all surveys, <italic>DSM-IV</italic> OCD has a combined lifetime prevalence of 4.1% and a 12-month prevalence of 3.0% (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Lifetime prevalence varies widely across countries, ranging from a low of 0.4% in Murcia, Spain to a high of 5.5% in Shenzhen, People&#x02019;s Republic of China. Although there is also wide variability within country groups, the overall pattern is for lifetime prevalence to be higher in LMICs (4.9%) compared to HICs (3.4%; <italic>&#x003c7;</italic><sup>2</sup><sub>1</sub>&#x02009;=&#x02009;16.9, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001). The pattern is very similar for 12-month prevalence, which ranges from 0.3 to 4.5% across countries yet is higher, on average, in LMICs (3.9%) than HICs (2.2%; <italic>&#x003c7;</italic><sup>2</sup><sub>1</sub>&#x02009;=&#x02009;27.3, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001).</p><p id="Par38">These estimates, which focus on diagnosed cases, miss the far larger number of individuals with subclinical obsessions and compulsions in the population (Additional File 1 Appendix Table&#x000a0;2). Fully 13.6% of the cross-national sample reported lifetime experiences of O/C. Most respondents reported only one type of O/C, most commonly involving harming (6.5%) or hoarding (5.9%). Type of O/C is only weakly associated with conditional probability of lifetime OCD, which ranges from a low of 35.5% (for hoarding) to a high of 48.3% (for &#x0201c;other&#x0201d; O/C whose content was not specified by respondents). By contrast, number of O/C is strongly associated with conditional probability of OCD, which increases monotonically from 16.9% of respondents who reported a single type to 67.4% of respondents who reported all five types assessed here. Among individuals with OCD, those reporting different O/C types do not differ markedly in persistence (72.2&#x02013;76.6% of lifetime cases have 12-month OCD) or severity (28.9&#x02013;38.5% of 12-month cases are moderate to severe). Instead, severity increases with number of O/C types, with moderate to severe OCD found in 10.9% of 12-month cases involving one type compared to 50.6% of cases involving all five types.</p></sec><sec id="Sec13"><title>Course</title><p id="Par39">OCD typically emerges early in life (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). First onsets most often occur in adolescence or early adulthood, with half of cases beginning by age 17 and more than 80% beginning by age 24. There is no evidence of sex differences in age of onset, with males and females having very similar age-of-onset curves.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Age of onset of OCD by sex</p><p>Abbreviation OCD obsessive-compulsive disorder</p><p>Cumulative age-of-onset distributions for first obsession or compulsion, shown separately for female and male respondents with lifetime OCD</p></caption><graphic xlink:href="12916_2025_4209_Fig1_HTML" id="MO1"/></fig></p><p id="Par40">Once OCD begins, it is highly persistent (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Nearly three-quarters (74.1%) of respondents with lifetime OCD still qualified for the disorder in the 12&#x000a0;months before the interview. Although persistence is lower on average in HICs (65.9%) than in LMICs (80.3%), this difference is driven mainly by two countries with very low persistence rates, Poland (23.1%) and Saudi Arabia (45.1%). In the eight other countries, persistence is the norm, reported by 70.7&#x02013;86.3% of lifetime cases.</p></sec><sec id="Sec14"><title>Severity</title><p id="Par41">In this community sample, most 12-month OCD cases score in the mild (47.0%) or very mild (27.5%) range on the Y-BOCS (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Another 22.9% of cases score in the moderate range, with fewer than 3% scoring as severe. OCD severity varies across countries: The modal 12-month case is very mild in Medellin, Colombia; mild in Australia; and moderate in Saudi Arabia. On average, OCD is more severe in HICs than in LMICs. This difference is driven mainly by very mild cases, which are more common in LMICs (32.4%) than in HICs (19.7%; <italic>&#x003c7;</italic><sup>2</sup><sub>1</sub>&#x02009;=&#x02009;8.2, <italic>p</italic>&#x02009;=&#x02009;0.004).
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Severity of 12-month <italic>DSM-IV</italic> OCD by country and country income group<sup>a</sup></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Country</th><th align="left" colspan="2">Severe</th><th align="left" colspan="2">Moderate</th><th align="left" colspan="2">Mild</th><th align="left" colspan="2">Very Mild</th><th align="left"/></tr><tr><th align="left">%</th><th align="left">(SE)</th><th align="left">%</th><th align="left">(SE)</th><th align="left">%</th><th align="left">(SE)</th><th align="left">%</th><th align="left">(SE)</th><th align="left">(n)</th></tr></thead><tbody><tr><td align="left">I. Low- or middle-income countries (LMIC)</td><td align="left">1.1</td><td align="left">(0.8)</td><td align="left">20.7</td><td align="left">(2.7)</td><td align="left">45.8</td><td align="left">(3.0)</td><td align="left">32.4</td><td align="left">(3.4)</td><td align="left">(420)</td></tr><tr><td align="left">&#x02003;Medellin, Colombia</td><td align="left">0.0</td><td align="left">(0.0)</td><td align="left">19.9</td><td align="left">(9.0)</td><td align="left">32.9</td><td align="left">(12.6)</td><td align="left">47.2</td><td align="left">(13.7)</td><td align="left">(19)</td></tr><tr><td align="left">&#x02003;Iraq</td><td align="left">3.4</td><td align="left">(2.5)</td><td align="left">23.0</td><td align="left">(4.7)</td><td align="left">38.3</td><td align="left">(5.8)</td><td align="left">35.2</td><td align="left">(6.8)</td><td align="left">(132)</td></tr><tr><td align="left">&#x02003;Shenzhen, People&#x02019;s Republic of China</td><td align="left">0.0</td><td align="left">(0.0)</td><td align="left">19.7</td><td align="left">(3.4)</td><td align="left">50.2</td><td align="left">(3.5)</td><td align="left">30.1</td><td align="left">(4.0)</td><td align="left">(265)</td></tr><tr><td align="left">&#x02003;Romania</td><td align="left">0.0</td><td align="left">(0.0)</td><td align="left">15.1</td><td align="left">(15.3)</td><td align="left">23.6</td><td align="left">(21.9)</td><td align="left">61.3</td><td align="left">(26.0)</td><td align="left">(4)</td></tr><tr><td align="left">II. High-income countries (HIC)</td><td align="left">5.2</td><td align="left">(2.2)</td><td align="left">26.3</td><td align="left">(3.0)</td><td align="left">48.9</td><td align="left">(3.8)</td><td align="left">19.7</td><td align="left">(2.7)</td><td align="left">(355)</td></tr><tr><td align="left">&#x02003;Argentina</td><td align="left">0.0</td><td align="left">(0.0)</td><td align="left">18.7</td><td align="left">(7.2)</td><td align="left">53.9</td><td align="left">(11.8)</td><td align="left">27.4</td><td align="left">(10.7)</td><td align="left">(27)</td></tr><tr><td align="left">&#x02003;Australia</td><td align="left">6.1</td><td align="left">(3.0)</td><td align="left">21.0</td><td align="left">(3.3)</td><td align="left">51.7</td><td align="left">(4.7)</td><td align="left">21.2</td><td align="left">(3.4)</td><td align="left">(218)</td></tr><tr><td align="left">&#x02003;Poland</td><td align="left">0.0</td><td align="left">(0.0)</td><td align="left">7.0</td><td align="left">(7.2)</td><td align="left">68.1</td><td align="left">(10.3)</td><td align="left">24.8</td><td align="left">(8.4)</td><td align="left">(12)</td></tr><tr><td align="left">&#x02003;Portugal</td><td align="left">2.0</td><td align="left">(2.0)</td><td align="left">23.9</td><td align="left">(9.9)</td><td align="left">52.1</td><td align="left">(10.8)</td><td align="left">22.0</td><td align="left">(8.6)</td><td align="left">(35)</td></tr><tr><td align="left">&#x02003;Saudi Arabia</td><td align="left">4.9</td><td align="left">(3.3)</td><td align="left">72.8</td><td align="left">(9.5)</td><td align="left">22.3</td><td align="left">(9.3)</td><td align="left">0.0</td><td align="left">(0.0)</td><td align="left">(60)</td></tr><tr><td align="left">&#x02003;Murcia, Spain</td><td align="left">0.0</td><td align="left">(0.0)</td><td align="left">0.0</td><td align="left">(0.0)</td><td align="left">24.5</td><td align="left">(24.0)</td><td align="left">75.5</td><td align="left">(24.0)</td><td align="left">(3)</td></tr><tr><td align="left">III. Total sample</td><td align="left">2.7</td><td align="left">(1.0)</td><td align="left">22.9</td><td align="left">(2.0)</td><td align="left">47.0</td><td align="left">(2.4)</td><td align="left">27.5</td><td align="left">(2.3)</td><td align="left">(775)</td></tr></tbody></table><table-wrap-foot><p><italic>Abbreviations</italic>
<italic>OCD</italic> obsessive-compulsive disorder, <italic>SE</italic> standard error</p><p><sup>a</sup>The severity categories are based on a scheme developed by [<xref ref-type="bibr" rid="CR21">21</xref>], which divides scores on the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) into five categories: Extreme (Y-BOCS = 32&#x02013;40), Severe (Y-BOCS = 24&#x02013;31), Moderate (Y-BOCS = 16&#x02013;23), Mild (Y-BOCS = 8&#x02013;15), and subthreshold (Y-BOCS = 0&#x02013;7). The subthreshold category is re-labeled Very Mild here because all 12-month OCD cases met the <italic>DSM-IV</italic> diagnostic threshold for the disorder. The Extreme category is omitted because none of the World Mental Health survey respondents had a Y-BOCS score <underline>&#x0003e;</underline> 32</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec15"><title>Treatment</title><p id="Par42">Cross-nationally, only 19.8% of respondents with 12-month OCD received treatment in the past year (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Individuals with more severe OCD are more likely to receive treatment: Treatment rates are highest among severe cases (52.5%), lower among moderate (20.9%) and mild (22.7%) cases, and lowest among very mild cases (10.7%; <italic>&#x003c7;</italic><sup>2</sup><sub>3</sub>&#x02009;=&#x02009;10.4, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.016). This general pattern is evident within each treatment sector but reaches statistical significance only in the specialty mental health, complementary-alternative medicine, and any non-health care sectors (<italic>&#x003c7;</italic><sup>2</sup><sub>3</sub>&#x02009;=&#x02009;8.4&#x02013;14.1, <italic>p</italic>&#x02009;=&#x02009;0.003&#x02013;0.041).
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Treatment seeking associated with 12-month <italic>DSM-IV</italic> OCD as a function of OCD severity and country income group<sup>a</sup></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Treatment sector</th><th align="left" colspan="2">Severe</th><th align="left" colspan="2">Moderate</th><th align="left" colspan="2">Mild</th><th align="left" colspan="2">Very Mild</th><th align="left" colspan="2">All 12-month OCD cases</th><th align="left"/></tr><tr><th align="left">%</th><th align="left">(SE)</th><th align="left">%</th><th align="left">(SE)</th><th align="left">%</th><th align="left">(SE)</th><th align="left">%</th><th align="left">(SE)</th><th align="left">%</th><th align="left">(SE)</th><th align="left"><italic>&#x003c7;&#x0feff;</italic><sup>2</sup><sub>3</sub></th></tr></thead><tbody><tr><td align="left" colspan="12">I. Health care</td></tr><tr><td align="left" colspan="12">&#x02003;a. Specialty mental health<sup>b</sup></td></tr><tr><td align="left">LMIC</td><td align="left">1.9</td><td align="left">(2.4)</td><td align="left">2.9</td><td align="left">(1.3)</td><td align="left">1.8</td><td align="left">(1.5)</td><td align="left">1.7</td><td align="left">(1.2)</td><td align="left">2.0</td><td align="left">(0.8)</td><td align="left">0.5</td></tr><tr><td align="left">HIC</td><td align="left">53.4</td><td align="left">(21.9)</td><td align="left">20.3*</td><td align="left">(4.9)</td><td align="left">35.1*</td><td align="left">(4.8)</td><td align="left">15.0*</td><td align="left">(6.1)</td><td align="left">28.2*</td><td align="left">(3.4)</td><td align="left">9.0**</td></tr><tr><td align="left">Total</td><td align="left">40.2</td><td align="left">(20.4)</td><td align="left">10.5</td><td align="left">(2.4)</td><td align="left">15.0</td><td align="left">(2.6)</td><td align="left">5.3</td><td align="left">(2.0)</td><td align="left">12.0</td><td align="left">(1.6)</td><td align="left">10.4**</td></tr><tr><td align="left" colspan="12">&#x02003;b. General medical<sup>c</sup></td></tr><tr><td align="left">LMIC</td><td align="left">9.7</td><td align="left">(10.4)</td><td align="left">2.3</td><td align="left">(1.2)</td><td align="left">1.7</td><td align="left">(1.5)</td><td align="left">3.3</td><td align="left">(2.6)</td><td align="left">2.4</td><td align="left">(1.1)</td><td align="left">1.2</td></tr><tr><td align="left">HIC</td><td align="left">58.1</td><td align="left">(18.5)</td><td align="left">23.4*</td><td align="left">(4.8)</td><td align="left">24.1*</td><td align="left">(3.6)</td><td align="left">15.3*</td><td align="left">(4.7)</td><td align="left">23.9*</td><td align="left">(3.0)</td><td align="left">3.5</td></tr><tr><td align="left">Total</td><td align="left">45.7</td><td align="left">(18.9)</td><td align="left">11.5</td><td align="left">(2.3)</td><td align="left">10.6</td><td align="left">(1.9)</td><td align="left">6.6</td><td align="left">(2.3)</td><td align="left">10.6</td><td align="left">(1.4)</td><td align="left">4.6</td></tr><tr><td align="left" colspan="12">&#x02003;c. Any health care<sup>d</sup></td></tr><tr><td align="left">LMIC</td><td align="left">9.7</td><td align="left">(10.4)</td><td align="left">5.1</td><td align="left">(2.1)</td><td align="left">2.1</td><td align="left">(1.5)</td><td align="left">4.5</td><td align="left">(2.8)</td><td align="left">3.6</td><td align="left">(1.2)</td><td align="left">2.1</td></tr><tr><td align="left">HIC</td><td align="left">64.5</td><td align="left">(16.7)</td><td align="left">33.2*</td><td align="left">(6.0)</td><td align="left">44.4*</td><td align="left">(5.1)</td><td align="left">26.6*</td><td align="left">(7.3)</td><td align="left">39.0*</td><td align="left">(3.5)</td><td align="left">5.5</td></tr><tr><td align="left">Total</td><td align="left">50.5</td><td align="left">(18.4)</td><td align="left">17.4</td><td align="left">(3.1)</td><td align="left">18.9</td><td align="left">(2.9)</td><td align="left">10.5</td><td align="left">(2.9)</td><td align="left">17.1</td><td align="left">(1.8)</td><td align="left">6.5</td></tr><tr><td align="left" colspan="12">II. Non-health care</td></tr><tr><td align="left" colspan="12">&#x02003;a. Human services<sup>e</sup></td></tr><tr><td align="left">LMIC</td><td align="left">7.8</td><td align="left">(9.4)</td><td align="left">1.1</td><td align="left">(0.7)</td><td align="left">2.5</td><td align="left">(1.9)</td><td align="left">0.0</td><td align="left">(0.0)</td><td align="left">1.5</td><td align="left">(0.9)</td><td align="left">-</td></tr><tr><td align="left">HIC</td><td align="left">38.7</td><td align="left">(25.5)</td><td align="left">1.8</td><td align="left">(1.2)</td><td align="left">5.0</td><td align="left">(1.7)</td><td align="left">0.0</td><td align="left">(0.0)</td><td align="left">4.9</td><td align="left">(2.2)</td><td align="left">-</td></tr><tr><td align="left">Total</td><td align="left">30.8</td><td align="left">(21.7)</td><td align="left">1.4</td><td align="left">(0.6)</td><td align="left">3.5</td><td align="left">(1.3)</td><td align="left">0.0</td><td align="left">(0.0)</td><td align="left">2.8</td><td align="left">(1.0)</td><td align="left">-</td></tr><tr><td align="left" colspan="12">&#x02003;b. CAM<sup>f</sup></td></tr><tr><td align="left">LMIC</td><td align="left">0.0</td><td align="left">(0.0)</td><td align="left">4.6</td><td align="left">(3.3)</td><td align="left">3.0</td><td align="left">(1.7)</td><td align="left">0.2</td><td align="left">(0.2)</td><td align="left">2.4</td><td align="left">(1.0)</td><td align="left">-</td></tr><tr><td align="left">HIC</td><td align="left">38.7</td><td align="left">(25.5)</td><td align="left">6.7</td><td align="left">(2.3)</td><td align="left">6.4</td><td align="left">(2.6)</td><td align="left">2.7</td><td align="left">(2.0)</td><td align="left">7.4</td><td align="left">(2.5)</td><td align="left">2.6</td></tr><tr><td align="left">Total</td><td align="left">28.8</td><td align="left">(22.0)</td><td align="left">5.5</td><td align="left">(2.1)</td><td align="left">4.3</td><td align="left">(1.5)</td><td align="left">0.9</td><td align="left">(0.6)</td><td align="left">4.3</td><td align="left">(1.1)</td><td align="left">8.4**</td></tr><tr><td align="left" colspan="12">&#x02003;c. Any non-health care<sup>g</sup></td></tr><tr><td align="left">LMIC</td><td align="left">7.8</td><td align="left">(9.4)</td><td align="left">5.7</td><td align="left">(3.3)</td><td align="left">5.1</td><td align="left">(2.5)</td><td align="left">0.2</td><td align="left">(0.2)</td><td align="left">3.7</td><td align="left">(1.3)</td><td align="left">7.0</td></tr><tr><td align="left">HIC</td><td align="left">38.7</td><td align="left">(25.5)</td><td align="left">8.5</td><td align="left">(2.6)</td><td align="left">10.0</td><td align="left">(2.9)</td><td align="left">2.7</td><td align="left">(2.0)</td><td align="left">9.7*</td><td align="left">(2.5)</td><td align="left">4.8</td></tr><tr><td align="left">Total</td><td align="left">30.8</td><td align="left">(21.7)</td><td align="left">6.9</td><td align="left">(2.2)</td><td align="left">7.1</td><td align="left">(1.9)</td><td align="left">0.9</td><td align="left">(0.6)</td><td align="left">6.0</td><td align="left">(1.3)</td><td align="left">14.1**</td></tr><tr><td align="left" colspan="12">III. Any treatment<sup>h</sup></td></tr><tr><td align="left">LMIC</td><td align="left">17.5</td><td align="left">(16.3)</td><td align="left">9.2</td><td align="left">(3.8)</td><td align="left">7.3</td><td align="left">(3.0)</td><td align="left">4.7</td><td align="left">(2.8)</td><td align="left">7.0</td><td align="left">(1.8)</td><td align="left">1.8</td></tr><tr><td align="left">HIC</td><td align="left">64.5</td><td align="left">(16.7)</td><td align="left">35.8*</td><td align="left">(6.1)</td><td align="left">46.1*</td><td align="left">(5.0)</td><td align="left">26.6*</td><td align="left">(7.3)</td><td align="left">40.5*</td><td align="left">(3.5)</td><td align="left">5.9</td></tr><tr><td align="left">Total</td><td align="left">52.5</td><td align="left">(18.2)</td><td align="left">20.9</td><td align="left">(3.6)</td><td align="left">22.7</td><td align="left">(3.2)</td><td align="left">10.7</td><td align="left">(2.9)</td><td align="left">19.8</td><td align="left">(1.9)</td><td align="left">10.4**</td></tr></tbody></table><table-wrap-foot><p><italic>Abbreviations</italic>
<italic>OCD</italic> obsessive-compulsive disorder, <italic>SE</italic> standard error, <italic>LMIC</italic> low- or middle-income countries, <italic>HIC</italic> high-income countries, <italic>CAM</italic> complementary-alternative medicine</p><p><sup>a</sup>The severity categories are based on a scheme developed by [<xref ref-type="bibr" rid="CR21">21</xref>], which divides scores on the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) into five categories: Extreme (Y-BOCS = 32&#x02013;40), Severe (Y-BOCS = 24&#x02013;31), Moderate (Y-BOCS = 16&#x02013;23), Mild (Y-BOCS = 8&#x02013;15), and subthreshold (Y-BOCS = 0&#x02013;7). The subthreshold category is re-labeled Very Mild here because all 12-month OCD cases met the <italic>DSM-IV</italic> diagnostic threshold for the disorder. The Extreme category is omitted because none of the World Mental Health survey respondents had a Y-BOCS score <underline>&#x0003e;</underline> 32</p><p><sup>b</sup>Includes psychiatrist, psychologist, or other mental health professional; social worker or counselor in a mental health specialty setting; use of a mental health helpline; or overnight admission for a mental health, drug, or alcohol problem, with a presumption of daily contact with a psychiatrist</p><p><sup>c</sup>Includes general practitioner, other medical doctor, nurse, occupational therapist, or other health care professional not previously mentioned</p><p><sup>d</sup>Includes the specialty mental health sector or the general medical sector</p><p><sup>e</sup>Includes religious or spiritual advisor, or social worker or counselor in any setting other than a specialty mental health setting</p><p><sup>f</sup>Includes any other type of healer, such as herbalist or homeopath; participation in an internet support group; or participation in a self-help group</p><p><sup>g</sup>Includes the human services sector or the CAM sector</p><p><sup>h</sup>Includes any treatment listed above</p><p>*Significant difference between country income groups (HIC versus LMIC) at the&#x000a0;0.05 level, two-sided test</p><p>**Significant difference between severity categories at the&#x000a0;0.05 level, two-sided test</p></table-wrap-foot></table-wrap></p><p id="Par43">Treatment rates are much higher in HICs (40.5%) than LMICs (7.0%; <italic>&#x003c7;</italic><sup>2</sup><sub>1</sub>&#x02009;=&#x02009;61.7, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001). Treatment setting also differs by country: OCD cases in HICs (39.0%) are much more likely than those in LMICs (3.6%) to receive treatment in a health care sector (<italic>&#x003c7;</italic><sup>2</sup><sub>1</sub>&#x02009;=&#x02009;71.5, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001). Specialty mental health care is especially rare in LMICs (2.0%), even for severe cases. The treatment disparity is smaller in non-health care sectors (<italic>&#x003c7;</italic><sup>2</sup><sub>1</sub>&#x02009;=&#x02009;4.5, <italic>p</italic>&#x02009;=&#x02009;0.035) due to the fact that HIC cases are far less likely to seek treatment in these sectors (9.7%) than in health care sectors. HIC and LMIC cases do not differ in the frequency with which they receive treatment in the human services sector (4.9% vs. 1.5%, respectively; <italic>&#x003c7;</italic><sup>2</sup><sub>1</sub>&#x02009;=&#x02009;2.2, <italic>p</italic>&#x02009;=&#x02009;0.138) nor in the complementary-alternative medicine sector (7.4% vs. 2.4%, respectively; <italic>&#x003c7;</italic><sup>2</sup><sub>1</sub>&#x02009;=&#x02009;3.6, <italic>p</italic>&#x02009;=&#x02009;0.059).</p></sec><sec id="Sec16"><title>Cross-national associations of socio-demographic variables with OCD-related outcomes</title><p id="Par44">Next, in a cross-national dataset aggregating across countries, we examined the relationship of each socio-demographic variable with the onset of <italic>DSM-IV</italic> OCD, controlling for country and for all other socio-demographic variables in the model (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). Female sex (OR&#x02009;=&#x02009;1.3) and younger age at interview (OR&#x02009;=&#x02009;2.5&#x02013;6.7) are both significantly associated with OCD onset. Education is also associated with OCD onset, with risk elevated for students (OR&#x02009;=&#x02009;2.4) and for individuals who completed low- or high-average, rather than high, levels of education (OR&#x02009;=&#x02009;1.8&#x02013;1.9) before OCD began. Lastly, marital status predicts OCD onset, with risk elevated for individuals who were never married (OR&#x02009;=&#x02009;1.4) before OCD began.
<table-wrap id="Tab4"><label>Table 4</label><caption><p>Multivariate associations of socio-demographic predictors with <italic>DSM-IV</italic> OCD onset, persistence, severity, and treatment</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Predictor</th><th align="left" colspan="2">Lifetime onset<sup>a</sup></th><th align="left" colspan="2">12-month persistence<sup>b,c</sup></th><th align="left" colspan="2">12-month severity<sup>b,d</sup></th><th align="left" colspan="2">12-month treatment<sup>b,e</sup></th></tr><tr><th align="left">OR</th><th align="left">(95% CI)</th><th align="left">OR</th><th align="left">(95% CI)</th><th align="left">OR</th><th align="left">(95% CI)</th><th align="left">OR</th><th align="left">(95% CI)</th></tr></thead><tbody><tr><td align="left" colspan="9">Gender&#x000a0;</td></tr><tr><td align="left">&#x02003;Female</td><td align="left">1.3*</td><td align="left">(1.0&#x02013;1.6)</td><td align="left">0.9</td><td align="left">(0.6&#x02013;1.5)</td><td align="left">1.1</td><td align="left">(0.7&#x02013;1.6)</td><td align="left">1.3</td><td align="left">(0.7&#x02013;2.3)</td></tr><tr><td align="left">&#x02003;Male</td><td align="left" colspan="2">1.0</td><td align="left" colspan="2">1.0</td><td align="left" colspan="2">1.0</td><td align="left" colspan="2">1.0</td></tr><tr><td align="left"><italic>x</italic><sup>2</sup><sub>1</sub></td><td align="left" colspan="2">5.3*</td><td align="left" colspan="2">0.1</td><td align="left" colspan="2">0.1</td><td align="left" colspan="2">0.7</td></tr><tr><td align="left" colspan="9">Age at interview</td></tr><tr><td align="left">&#x02003;18&#x02013;29</td><td align="left">6.7*</td><td align="left">(4.2&#x02013;10.7)</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td></tr><tr><td align="left">&#x02003;30&#x02013;44</td><td align="left">3.7*</td><td align="left">(2.4&#x02013;5.8)</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td></tr><tr><td align="left">&#x02003;45&#x02013;59</td><td align="left">2.5*</td><td align="left">(1.7&#x02013;3.7)</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td></tr><tr><td align="left">&#x02003;60+</td><td align="left" colspan="2">1.0</td><td align="left" colspan="2">-</td><td align="left" colspan="2">-</td><td align="left" colspan="2">-</td></tr><tr><td align="left"><italic>x</italic><sup>2</sup><sub>3</sub></td><td align="left" colspan="2">73.6*</td><td align="left" colspan="2">-</td><td align="left" colspan="2">-</td><td align="left" colspan="2">-</td></tr><tr><td align="left">Age of onset of OCD<sup>f</sup></td><td align="left">-</td><td align="left">-</td><td align="left">1.0</td><td align="left">(1.0&#x02013;1.0)</td><td align="left">1.0*</td><td align="left">(0.9&#x02013;1.0)</td><td align="left">1.0</td><td align="left">(0.9&#x02013;1.0)</td></tr><tr><td align="left"><italic>x</italic><sup>2</sup><sub>1</sub></td><td align="left" colspan="2">-</td><td align="left" colspan="2">0.3</td><td align="left" colspan="2">4.3*</td><td align="left" colspan="2">2.5</td></tr><tr><td align="left">Time since onset of OCD<sup>f</sup></td><td align="left">-</td><td align="left">-</td><td align="left">1.0</td><td align="left">(1.0&#x02013;1.0)</td><td align="left">1.0</td><td align="left">(1.0&#x02013;1.0)</td><td align="left">1.0</td><td align="left">(1.0&#x02013;1.0)</td></tr><tr><td align="left"><italic>x</italic><sup>2</sup><sub>1</sub></td><td align="left" colspan="2">-</td><td align="left" colspan="2">1.3</td><td align="left" colspan="2">0.3</td><td align="left" colspan="2">0.7</td></tr><tr><td align="left" colspan="9">Education</td></tr><tr><td align="left">&#x02003;Student</td><td align="left">2.4*</td><td align="left">(1.8&#x02013;3.1)</td><td align="left">1.0</td><td align="left">(0.4&#x02013;2.4)</td><td align="left">1.1</td><td align="left">(0.4&#x02013;2.6)</td><td align="left">0.6</td><td align="left">(0.3&#x02013;1.4)</td></tr><tr><td align="left">&#x02003;Low</td><td align="left">1.4</td><td align="left">(0.8&#x02013;2.3)</td><td align="left">0.6</td><td align="left">(0.2&#x02013;2.5)</td><td align="left">1.8</td><td align="left">(0.5&#x02013;6.3)</td><td align="left">0.6</td><td align="left">(0.2&#x02013;1.8)</td></tr><tr><td align="left">&#x02003;Low-average</td><td align="left">1.9*</td><td align="left">(1.3&#x02013;2.9)</td><td align="left">1.0</td><td align="left">(0.3&#x02013;3.1)</td><td align="left">1.2</td><td align="left">(0.4&#x02013;3.4)</td><td align="left">1.3</td><td align="left">(0.5&#x02013;3.7)</td></tr><tr><td align="left">&#x02003;High-average</td><td align="left">1.6*</td><td align="left">(1.1&#x02013;2.5)</td><td align="left">0.7</td><td align="left">(0.3&#x02013;1.7)</td><td align="left">3.9*</td><td align="left">(1.4&#x02013;10.3)</td><td align="left">0.6</td><td align="left">(0.2&#x02013;1.5)</td></tr><tr><td align="left">&#x02003;High</td><td align="left" colspan="2">1.0</td><td align="left" colspan="2">1.0</td><td align="left" colspan="2">1.0</td><td align="left" colspan="2">1.0</td></tr><tr><td align="left"><italic>x</italic><sup>2</sup><sub>4</sub></td><td align="left" colspan="2">42.6*</td><td align="left" colspan="2">3.2</td><td align="left" colspan="2">13.0*</td><td align="left" colspan="2">4.6</td></tr><tr><td align="left" colspan="9">Marital status</td></tr><tr><td align="left">&#x02003;Never married</td><td align="left">1.4*</td><td align="left">(1.0&#x02013;1.9)</td><td align="left">1.1</td><td align="left">(0.5&#x02013;2.1)</td><td align="left">1.8</td><td align="left">(0.8&#x02013;3.7)</td><td align="left">0.4*</td><td align="left">(0.2&#x02013;0.9)</td></tr><tr><td align="left">&#x02003;Previously married</td><td align="left">0.6</td><td align="left">(0.3&#x02013;1.2)</td><td align="left">2.6</td><td align="left">(0.7&#x02013;9.4)</td><td align="left">5.5*</td><td align="left">(1.5&#x02013;19.4)</td><td align="left">2.0</td><td align="left">(0.5&#x02013;8.4)</td></tr><tr><td align="left">&#x02003;Currently married</td><td align="left" colspan="2">1.0</td><td align="left" colspan="2">1.0</td><td align="left" colspan="2">1.0</td><td align="left" colspan="2">1.0</td></tr><tr><td align="left"><italic>x</italic><sup>2</sup><sub>2</sub></td><td align="left" colspan="2">8.6*</td><td align="left" colspan="2">2.1</td><td align="left" colspan="2">&#x000a0;7.8*</td><td align="left" colspan="2">8.2*</td></tr><tr><td align="left" colspan="9">12-month severity</td></tr><tr><td align="left">&#x02003;Severe/moderate<sup>d</sup></td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">1.2</td><td align="left">(0.6&#x02013;2.2)</td></tr><tr><td align="left">&#x02003;Mild/very mild</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left" colspan="2">1.0</td></tr><tr><td align="left"><italic>x</italic><sup>2</sup><sub>1</sub></td><td align="left" colspan="2">-</td><td align="left" colspan="2">-</td><td align="left" colspan="2">-</td><td align="left" colspan="2">0.3</td></tr><tr><td align="left">(<italic>n</italic>)</td><td align="left" colspan="2">(21,479)</td><td align="left" colspan="2">(955)</td><td align="left" colspan="2">(767)</td><td align="left" colspan="2">(767)</td></tr></tbody></table><table-wrap-foot><p><italic>Abbreviations</italic>
<italic>OCD</italic> obsessive-compulsive disorder, <italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p><p><sup>a</sup>Based on a multivariable discrete-time survival model with person-year as the unit of analysis, estimated within the total sample of respondents who were assessed for OCD. Each OR shows the association between one predictor and the lifetime onset of OCD, controlling for country and for all other socio-demographic variables. Education and marital status were time-varying, reflecting the respondent&#x02019;s status as of the year prior to OCD onset among lifetime cases</p><p><sup>b</sup>Based on a multivariate person-level logistic regression model. Each OR shows the association between one predictor and a 12-month OCD-related outcome, controlling for country and for all other socio-demographic variables. Education and marital status were time-invariant, reflecting the respondent&#x02019;s status at the time of OCD onset</p><p><sup>c</sup>Predicted 12-month OCD within the subsample of lifetime cases whose age of onset of OCD was at least two years earlier than their age at interview</p><p><sup>d</sup>Predicted a Y-BOCS score in the Severe or Moderate range (i.e., a score of at least 16 out of 40; [<xref ref-type="bibr" rid="CR21">21</xref>]) among respondents with 12-month OCD</p><p><sup>e</sup>Predicted any 12-month treatment among respondents with 12-month OCD</p><p><sup>f</sup>Measured as a continuous variable</p><p>*Significant at&#x000a0;the 0.05 level, two-sided test</p></table-wrap-foot></table-wrap></p><p id="Par45">None of the socio-demographic variables considered here predict the persistence of OCD. However, several variables predict greater severity of OCD, operationalized as a score in the severe or moderate (rather than mild or very mild) range on the Y-BOCS. OCD is modestly but significantly more severe for individuals with an earlier age of onset of OCD (OR&#x02009;=&#x02009;1.0). OCD is considerably more severe for individuals who, when their OCD began, had a high-average level of education (rather than a high level; OR&#x02009;=&#x02009;3.9) and were previously married (rather than currently married; OR&#x02009;=&#x02009;5.5). Marital status also predicts treatment among 12-month OCD cases, with never-married individuals less likely to receive treatment than individuals who were married when OCD began.</p></sec><sec id="Sec17"><title>Cross-national associations of comorbid disorders with OCD-related outcomes</title><p id="Par46">Approximately half (50.3%) of individuals with lifetime OCD also qualify for at least one of the nine other lifetime <italic>DSM-IV</italic> disorders assessed here (Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>). Lifetime comorbidity is highest with mood disorders (35.0%), especially major depressive disorder (22.7%). Comorbid anxiety disorders are also common (27.1%), especially social phobia (14.6%). Conversely, only 9.0% of respondents with another lifetime mental disorder have a comorbid diagnosis of OCD. Comorbid OCD is most often reported by individuals with bipolar spectrum disorder (23.1%) and ADHD (16.6%). OCD begins first in 39.3% of comorbid cases, and this is particularly common when the comorbid condition is a substance use disorder (58.9%) or a mood disorder (58.2%). More often, OCD begins second (49.2%), and this is particularly common when the comorbid condition is ADHD (89.1%) or an anxiety disorder (50.4%). Same-year onsets occur in 11.6% of cases and are concentrated among anxiety disorders, especially panic disorder (24.0%).
<table-wrap id="Tab5"><label>Table 5</label><caption><p>Conditional prevalence and temporal order of lifetime comorbid disorders with <italic>DSM-IV</italic> OCD</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="4">Disorder</th><th align="left" rowspan="3" colspan="2">Prevalence of lifetime comorbid disorder among respondents with lifetime OCD<sup>a</sup></th><th align="left" rowspan="3" colspan="2">Prevalence of lifetime OCD among respondents with lifetime comorbid disorder<sup>b</sup></th><th align="left" colspan="6"/></tr><tr><th align="left" colspan="6">Temporal order of OCD and comorbid disorder<sup>c</sup></th></tr><tr><th align="left" colspan="2">OCD first</th><th align="left" colspan="2">OCD second</th><th align="left" colspan="2">Same-year onset</th></tr><tr><th align="left">%</th><th align="left">(SE)</th><th align="left">%</th><th align="left">(SE)</th><th align="left">%</th><th align="left">(SE)</th><th align="left">%</th><th align="left">(SE)</th><th align="left">%</th><th align="left">(SE)</th></tr></thead><tbody><tr><td align="left">Any anxiety disorder</td><td align="left">27.1</td><td align="left">(1.8)</td><td align="left">11.9</td><td align="left">(0.8)</td><td align="left">36.4</td><td align="left">(3.7)</td><td align="left">50.4</td><td align="left">(3.7)</td><td align="left">13.3</td><td align="left">(2.6)</td></tr><tr><td align="left">&#x02003;Panic disorder with/without agoraphobia</td><td align="left">6.7</td><td align="left">(1.0)</td><td align="left">15.8</td><td align="left">(2.2)</td><td align="left">39.2</td><td align="left">(8.6)</td><td align="left">36.9</td><td align="left">(7.8)</td><td align="left">24.0</td><td align="left">(8.2)</td></tr><tr><td align="left">&#x02003;Social phobia</td><td align="left">14.6</td><td align="left">(1.5)</td><td align="left">15.3</td><td align="left">(1.4)</td><td align="left">29.1</td><td align="left">(5.1)</td><td align="left">53.1</td><td align="left">(5.0)</td><td align="left">17.8</td><td align="left">(4.0)</td></tr><tr><td align="left">&#x02003;Generalized anxiety disorder</td><td align="left">7.8</td><td align="left">(1.1)</td><td align="left">10.2</td><td align="left">(1.4)</td><td align="left">58.0</td><td align="left">(7.4)</td><td align="left">24.4</td><td align="left">(5.5)</td><td align="left">17.5</td><td align="left">(7.1)</td></tr><tr><td align="left">&#x02003;Posttraumatic stress disorder</td><td align="left">9.9</td><td align="left">(1.4)</td><td align="left">12.0</td><td align="left">(1.6)</td><td align="left">52.0</td><td align="left">(6.1)</td><td align="left">38.2</td><td align="left">(6.1)</td><td align="left">9.8</td><td align="left">(4.2)</td></tr><tr><td align="left">Any mood disorder</td><td align="left">35.0</td><td align="left">(2.0)</td><td align="left">12.7</td><td align="left">(0.8)</td><td align="left">58.2</td><td align="left">(3.5)</td><td align="left">30.4</td><td align="left">(3.1)</td><td align="left">11.4</td><td align="left">(2.0)</td></tr><tr><td align="left">&#x02003;Major depressive disorder</td><td align="left">22.7</td><td align="left">(1.7)</td><td align="left">10.2</td><td align="left">(0.8)</td><td align="left">59.9</td><td align="left">(4.7)</td><td align="left">28.1</td><td align="left">(3.8)</td><td align="left">12.0</td><td align="left">(2.4)</td></tr><tr><td align="left">&#x02003;Bipolar spectrum disorder<sup>d</sup></td><td align="left">13.0</td><td align="left">(1.5)</td><td align="left">23.1</td><td align="left">(2.3)</td><td align="left">57.0</td><td align="left">(5.7)</td><td align="left">32.8</td><td align="left">(5.4)</td><td align="left">10.1</td><td align="left">(3.1)</td></tr><tr><td align="left">Attention-deficit/hyperactivity disorder<sup>e</sup></td><td align="left">3.1</td><td align="left">(0.7)</td><td align="left">16.6</td><td align="left">(3.5)</td><td align="left">5.7</td><td align="left">(3.6)</td><td align="left">89.1</td><td align="left">(4.9)</td><td align="left">5.2</td><td align="left">(3.2)</td></tr><tr><td align="left">Any substance use disorder</td><td align="left">14.7</td><td align="left">(1.4)</td><td align="left">6.1</td><td align="left">(0.6)</td><td align="left">58.9</td><td align="left">(5.6)</td><td align="left">33.5</td><td align="left">(5.3)</td><td align="left">7.6</td><td align="left">(2.7)</td></tr><tr><td align="left">&#x02003;Alcohol abuse or dependence</td><td align="left">12.7</td><td align="left">(1.4)</td><td align="left">5.9</td><td align="left">(0.7)</td><td align="left">60.3</td><td align="left">(6.4)</td><td align="left">30.3</td><td align="left">(5.7)</td><td align="left">9.5</td><td align="left">(3.9)</td></tr><tr><td align="left">&#x02003;Drug abuse or dependence</td><td align="left">6.6</td><td align="left">(0.9)</td><td align="left">8.9</td><td align="left">(1.3)</td><td align="left">55.4</td><td align="left">(7.4)</td><td align="left">35.2</td><td align="left">(6.7)</td><td align="left">9.4</td><td align="left">(4.6)</td></tr><tr><td align="left">Any disorder</td><td align="left">50.3</td><td align="left">(2.3)</td><td align="left">9.0</td><td align="left">(0.5)</td><td align="left">39.3</td><td align="left">(2.6)</td><td align="left">49.2</td><td align="left">(2.7)</td><td align="left">11.6</td><td align="left">(1.7)</td></tr></tbody></table><table-wrap-foot><p><italic>Abbreviations</italic>
<italic>OCD</italic> obsessive-compulsive disorder, <italic>SE</italic> standard error</p><p><sup>a</sup>Percentages reflect the proportion of respondents with the lifetime disorder in each row who also qualified for lifetime OCD</p><p><sup>b</sup>Percentages reflect the proportion of respondents with lifetime OCD who also qualified for the lifetime disorder in each row</p><p><sup>c</sup>Temporal order is based on the age of onset reported for OCD and for the lifetime disorder in each row</p><p><sup>d</sup>Includes bipolar I disorder, bipolar II disorder, or subthreshold bipolar disorder</p><p><sup>e</sup>Restricted to respondents ages 18&#x02013;44 for Portugal</p></table-wrap-foot></table-wrap></p><p id="Par47">Compared to individuals with no prior mental disorder, individuals with any prior disorder have more than a fourfold increase in risk of subsequently developing OCD (OR&#x02009;=&#x02009;4.4) (Additional File 1 Appendix Table&#x000a0;3). When tested separately in univariate models, every lifetime disorder other than alcohol use disorder significantly predicts the subsequent first onset of OCD. The odds ratios are attenuated, yet most remain significant, in a multivariate model controlling for all other comorbid disorders as well as socio-demographic variables (Table&#x000a0;<xref rid="Tab6" ref-type="table">6</xref>). OCD is most likely to develop among individuals with earlier-occurring bipolar spectrum disorder (OR&#x02009;=&#x02009;4.4) and ADHD (OR&#x02009;=&#x02009;3.9). Risk of OCD is also heightened among individuals with earlier-occurring social phobia (OR&#x02009;=&#x02009;2.4), panic disorder (OR&#x02009;=&#x02009;1.9), posttraumatic stress disorder (OR&#x02009;=&#x02009;1.9), and major depressive disorder (OR&#x02009;=&#x02009;1.6).
<table-wrap id="Tab6"><label>Table 6</label><caption><p>Multivariate associations of temporally prior lifetime disorders with subsequent <italic>DSM-IV</italic> OCD onset, persistence, severity, and treatment<sup>a</sup></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Temporally prior disorder</th><th align="left" colspan="2">Lifetime onset<sup>b</sup></th><th align="left" colspan="2">12-month persistence<sup>c</sup></th><th align="left" colspan="2">12-month severity<sup>d</sup></th><th align="left" colspan="2">12-month treatment<sup>e</sup></th></tr><tr><th align="left">OR</th><th align="left">(95% CI)</th><th align="left">OR</th><th align="left">(95% CI)</th><th align="left">OR</th><th align="left">(95% CI)</th><th align="left">OR</th><th align="left">(95% CI)</th></tr></thead><tbody><tr><td align="left" colspan="9">Anxiety disorder</td></tr><tr><td align="left">&#x02003;Panic disorder with/without agoraphobia</td><td align="left">1.9*</td><td align="left">(1.0&#x02013;3.5)</td><td align="left">0.3*</td><td align="left">(0.1&#x02013;0.7)</td><td align="left">0.6</td><td align="left">(0.2&#x02013;1.7)</td><td align="left">3.2*</td><td align="left">(1.1&#x02013;9.9)</td></tr><tr><td align="left">&#x02003;Social phobia</td><td align="left">2.4*</td><td align="left">(1.6&#x02013;3.4)</td><td align="left">1.7</td><td align="left">(0.9&#x02013;3.1)</td><td align="left">2.1*</td><td align="left">(1.1&#x02013;4.1)</td><td align="left">3.5*</td><td align="left">(1.8&#x02013;6.7)</td></tr><tr><td align="left">&#x02003;Generalized anxiety disorder</td><td align="left">1.0</td><td align="left">(0.6&#x02013;1.9)</td><td align="left">0.7</td><td align="left">(0.3&#x02013;1.8)</td><td align="left">4.3*</td><td align="left">(1.4&#x02013;13.2)</td><td align="left">0.9</td><td align="left">(0.3&#x02013;2.4)</td></tr><tr><td align="left">&#x02003;Posttraumatic stress disorder</td><td align="left">1.9*</td><td align="left">(1.1&#x02013;3.4)</td><td align="left">1.8</td><td align="left">(0.8&#x02013;3.9)</td><td align="left">2.6</td><td align="left">(1.0&#x02013;6.6)</td><td align="left">1.9</td><td align="left">(0.7&#x02013;4.7)</td></tr><tr><td align="left" colspan="9">Mood disorder</td></tr><tr><td align="left">&#x02003;Major depressive disorder</td><td align="left">1.6*</td><td align="left">(1.1&#x02013;2.4)</td><td align="left">0.7</td><td align="left">(0.4&#x02013;1.3)</td><td align="left">1.7</td><td align="left">(0.9&#x02013;3.4)</td><td align="left">1.0</td><td align="left">(0.5&#x02013;2.2)</td></tr><tr><td align="left">&#x02003;Bipolar spectrum disorder<sup>f</sup></td><td align="left">4.4*</td><td align="left">(2.6&#x02013;7.6)</td><td align="left">1.1</td><td align="left">(0.4&#x02013;2.8)</td><td align="left">0.8</td><td align="left">(0.4&#x02013;1.8)</td><td align="left">1.1</td><td align="left">(0.5&#x02013;2.7)</td></tr><tr><td align="left" colspan="9">Externalizing disorder</td></tr><tr><td align="left">&#x02003;Attention-deficit/hyperactivity disorder<sup>g</sup></td><td align="left">3.9*</td><td align="left">(2.3&#x02013;6.6)</td><td align="left">0.5</td><td align="left">(0.1&#x02013;1.4)</td><td align="left">1.3</td><td align="left">(0.5&#x02013;3.6)</td><td align="left">1.8</td><td align="left">(0.3&#x02013;9.4)</td></tr><tr><td align="left" colspan="9">Substance use disorder</td></tr><tr><td align="left">&#x02003;Alcohol abuse or dependence</td><td align="left">1.0</td><td align="left">(0.6&#x02013;1.6)</td><td align="left">2.9*</td><td align="left">(1.0&#x02013;8.1)</td><td align="left">0.4</td><td align="left">(0.2&#x02013;1.1)</td><td align="left">1.1</td><td align="left">(0.4&#x02013;3.1)</td></tr><tr><td align="left">&#x02003;Drug abuse or dependence</td><td align="left">1.4</td><td align="left">(0.8&#x02013;2.4)</td><td align="left">1.5</td><td align="left">(0.5&#x02013;4.4)</td><td align="left">0.9</td><td align="left">(0.4&#x02013;2.4)</td><td align="left">0.8</td><td align="left">(0.3&#x02013;2.4)</td></tr><tr><td align="left">(<italic>n</italic>)</td><td align="left" colspan="2">(21,479)</td><td align="left" colspan="2">(955)</td><td align="left" colspan="2">(767)</td><td align="left" colspan="2">(767)</td></tr></tbody></table><table-wrap-foot><p><italic>Abbreviations</italic>
<italic>OCD</italic> obsessive-compulsive disorder, <italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval</p><p><sup>a</sup>Base models were identical to those in Table <xref rid="Tab4" ref-type="table">4</xref>. Comorbid disorders were added to those models here to explore multivariate associations of temporally prior lifetime disorders with subsequent OCD onset, persistence, severity, and treatment. In the model predicting lifetime onset, comorbid disorders were time-varying, reflecting the respondent&#x02019;s diagnostic status as of the year prior to OCD onset. In the models predicting 12-month prevalence, severity, and treatment, comorbid disorders were time-invariant, reflecting the respondent&#x02019;s diagnostic status at the time of OCD onset. Each OR shows the association between one temporally prior disorder and an OCD-related outcome, controlling for all other disorders, socio-demographic variables, and country</p><p><sup>b</sup>Predicted lifetime onset of OCD in the total sample of respondents who were assessed for OCD</p><p><sup>c</sup>Predicted 12-month OCD within the subsample of lifetime cases whose age of onset of OCD was at least two years earlier than their age at interview</p><p><sup>d</sup>Predicted a Y-BOCS score in the Severe or Moderate range (i.e., a score of at least 16 out of 40; [<xref ref-type="bibr" rid="CR21">21</xref>]) among respondents with 12-month OCD</p><p><sup>e</sup>Predicted any 12-month treatment among respondents with 12-month OCD, including 12-month severity as an additional covariate</p><p><sup>f</sup>Includes bipolar I disorder, bipolar II disorder, or subthreshold bipolar disorder</p><p><sup>g</sup>Restricted to respondents ages 18&#x02013;44 for Portugal</p><p>*Significant at the&#x000a0;0.05 level, two-sided test</p></table-wrap-foot></table-wrap></p><p id="Par48">Once OCD has begun, comorbid disorders are less reliable predictors of its persistence (Additional File 1 Appendix Table&#x000a0;3). Compared to respondents with no comorbid disorder at the time of OCD onset, those with a comorbid disorder are no more likely to still have OCD in the 12&#x000a0;months before the interview (OR&#x02009;=&#x02009;1.1). The sole exception is that persistence is heightened specifically in individuals who have an alcohol use disorder at the time of OCD onset, an effect that holds when controlling for all other disorders in a multivariate model (OR&#x02009;=&#x02009;2.9) (Table&#x000a0;<xref rid="Tab6" ref-type="table">6</xref>). Unexpectedly, in the same multivariate model, persistence is <italic>decreased</italic> in individuals who have panic disorder at the time of OCD onset (OR&#x02009;=&#x02009;0.3).</p><p id="Par49">Finally, having a comorbid disorder when OCD begins predicts subsequent OCD severity (OR&#x02009;=&#x02009;2.4) and treatment (OR&#x02009;=&#x02009;1.9) (Additional File 1 Appendix Table&#x000a0;3). After controlling for all other disorders, only generalized anxiety disorder (OR&#x02009;=&#x02009;4.3) and social phobia (OR&#x02009;=&#x02009;2.1) are associated with increased severity of 12-month OCD (Table&#x000a0;6). Social phobia is also associated with treatment seeking among 12-month OCD cases (OR&#x02009;=&#x02009;3.5), as is panic disorder (OR&#x02009;=&#x02009;3.2).</p></sec></sec><sec id="Sec18"><title>Discussion</title><p id="Par50">The present findings are tempered by several limitations. First, we used data from representative community surveys in 10 countries across the globe, enhancing the generalizability of our results. However, as some surveys were regionally rather than nationally representative, and as prevalence estimates were highly heterogenous across these surveys and across past epidemiological studies of OCD [<xref ref-type="bibr" rid="CR1">1</xref>], our estimates cannot be taken as fully representative of the world. There is a particular dearth of community studies of OCD in Africa that remains to be addressed. Second, to our knowledge, our large cross-national sample included more OCD cases (3665 lifetime cases, 775 12-month cases) than any previous study, increasing statistical power to detect predictors of OCD-related outcomes. That said, some countries contributed relatively few OCD cases, especially for analyses of 12-month outcomes. Third, concerns have been raised about the extent to which lay-administered structured diagnostic interviews overestimate OCD prevalence [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. It is reassuring that CIDI diagnoses of OCD are moderately to highly concordant with clinician diagnoses [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. Nevertheless, many respondents who were diagnosed with 12-month OCD had very mild symptoms (i.e., Y-BOCS scores lower than 8), raising questions about their clinical significance or about possible cross-cultural differences in clinical presentation that the Y-BOCS may miss [<xref ref-type="bibr" rid="CR33">33</xref>]. While the literature has emphasized the universality of OCD symptoms [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>], further work is needed to explore variability in symptom experience and expression that may have implications for diagnosis [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Fourth, the ages at which predictors and outcomes occurred were assessed retrospectively. Although we used a probing strategy that has been shown to promote accurate dating [<xref ref-type="bibr" rid="CR37">37</xref>] and we required time-varying predictors and outcomes to be separated by at least a year, the temporal findings should be viewed as tentative pending replication in prospective longitudinal studies. Fifth, we focused on nine common comorbid disorders that share etiologically meaningful relationships with OCD. However, other potentially comorbid disorders were omitted, including obsessive-compulsive related disorders such as hoarding disorder and body dysmorphic disorder, eating disorders, and psychotic disorders [<xref ref-type="bibr" rid="CR38">38</xref>]. Consequently, our results likely represent lower-bound estimates of the extent of comorbidity and the ability of temporally prior mental disorders to predict OCD-related outcomes. Sixth, we assessed OCD using CIDI 3.0, which is based on <italic>DSM-IV</italic> diagnostic criteria. As such, we used a narrower definition of obsessions than <italic>DSM-5</italic>, which removed the requirements that obsessions cause marked anxiety or distress and are recognized to be a product of the individual&#x02019;s own mind, and we did not perform a detailed assessment of the OCD insight specifier. Finally, we categorized Y-BOCS scores using a method designed to capture OCD cases across the full severity continuum. While this approach is appropriate for community samples, which vary widely in severity, it is less likely to be suitable for clinical samples, which typically require higher severity thresholds.</p><p id="Par51">Bearing these considerations in mind, lifetime prevalence of OCD was 4.1% and 12-month prevalence was 3.0% across all surveys combined. An additional 9.5% of respondents reported lifetime experiences of obsessions or compulsions but did not qualify for an OCD diagnosis. These data are consistent with previous evidence, primarily from HICs, that OCD is more common than originally thought [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR8">8</xref>] and that in the general population there is also a high prevalence of subclinical OCD [<xref ref-type="bibr" rid="CR6">6</xref>]. The gap between early informal prevalence estimates and more recent data-based prevalence estimates may reflect that some individuals with OCD conceal their symptoms or do not view their symptoms as part of a treatable condition&#x02014;factors that may in turn delay diagnosis and appropriate treatment [<xref ref-type="bibr" rid="CR39">39</xref>]. Although OCD is often conceptualized as a discrete condition that is either present or absent, the high prevalence of subclinical presentations highlights that&#x02014;as in the case of mood and anxiety disorders&#x02014;there is a spectrum from wellness to illness, with even mild forms of illness potentially impairing and deserving of attention [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>].</p><p id="Par52">The finding that OCD prevalence rates are higher in LMICs than HICs is noteworthy, given that other common mental disorders are more prevalent in HICs than LMICs [<xref ref-type="bibr" rid="CR42">42</xref>]. Many factors could account for the variability in prevalence across countries. Despite efforts to ensure methodological consistency across surveys, variations in characteristics such as sampling frames, quality control procedures, and interview length prevented full equivalence [<xref ref-type="bibr" rid="CR15">15</xref>]. Further, the CIDI 3.0 translation protocol, although rigorous, may not have fully overcome the complex challenges of adapting a single interview for a diverse set of languages and cultures [<xref ref-type="bibr" rid="CR16">16</xref>]. Cultural factors may also have influenced response patterns: In LMICs, for example, stigma surrounding mental illnesses may have decreased disclosure of symptoms, while prevalent religious rituals may have increased reporting of some OCD symptoms [<xref ref-type="bibr" rid="CR43">43</xref>]. Although higher OCD prevalence rates in lower-income countries are more likely attributable to methodological than substantive differences, OCD has been linked to infectious conditions that are more common in LMICs than HICs [<xref ref-type="bibr" rid="CR44">44</xref>].</p><p id="Par53">Notably, the proportion of cases with mild or very mild symptoms is also higher in LMICs, while the proportion of cases with moderate or severe symptoms is higher in HICs. This is consistent with the large majority of disorders assessed in the WMH surveys, for which the proportion of individuals reporting severe impairment is lower in LMICs [<xref ref-type="bibr" rid="CR43">43</xref>] despite the relative scarcity of mental health resources and lower treatment uptake in these countries compared to HICs. It is&#x000a0;possible that, as has been observed for other mental disorders [<xref ref-type="bibr" rid="CR45">45</xref>], the functional impact of OCD is indeed lower in lower-income countries. This could reflect cross-national differences in role expectations (e.g., less rigid role demands) or social structures (e.g., stronger community and familial support systems). Further work is needed to probe differences in OCD prevalence and impairment across LMICs and HICs, including investigation of biopsychosocial factors that may influence differential symptom expression and reporting [<xref ref-type="bibr" rid="CR46">46</xref>&#x02013;<xref ref-type="bibr" rid="CR48">48</xref>].</p><p id="Par54">The early onset and high persistence of OCD found here are consistent with previous work emphasizing the chronic course of this condition [<xref ref-type="bibr" rid="CR6">6</xref>]. These findings have implications for clinical services and public health policy, particularly the importance of early detection and intervention [<xref ref-type="bibr" rid="CR49">49</xref>]. Our finding that age of onset of OCD is similar in males and females is noteworthy, given previous inconsistent findings based on smaller samples [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. However, unlike community surveys, clinical evaluation allows careful assessment of neurological features such as motor and vocal tics, and this more readily allows the delineation of an OCD subgroup that has an earlier onset, is more common in males, and involves a greater likelihood of tics [<xref ref-type="bibr" rid="CR50">50</xref>].</p><p id="Par55">Cross-nationally, fewer than one-fifth of respondents with 12-month OCD received treatment in the past year. This estimate reflects treatment for any mental health condition, suggesting that even fewer respondents received treatment specifically for OCD. In general, more severe OCD was associated with greater probability of treatment. However, treatment patterns also differed strikingly across countries. Treatment rates were much higher in HICs (40.5%) than LMICs (7.0%). Furthermore, in HICs treatment was received primarily in health care settings, most often in the specialty mental health sector, while in LMICs treatment was equally likely in health care and non-health care settings. This is concerning given that efficacious interventions for OCD, such as exposure and response prevention, are not typically available outside of specialty mental health settings. Taken together, these findings are consistent with prior descriptions of lower rates and worse quality of treatment of common mental disorders in LMICs, due to factors spanning structural barriers such as limited access to health services and attitudinal barriers such as lower perceived need for treatment [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>].</p><p id="Par56">Multivariate models identified distinct predictors of OCD onset, persistence, severity, and treatment within the total sample. Consistent with previous work [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>], female sex and younger age are associated with OCD onset; so are being a student, having low-average or high-average education, and having never been married before OCD began. Extending previous work, we show that younger age of onset, high-average education, and no longer being married are associated with more severe OCD, and that never being married is associated with lower odds of treatment. That socio-demographic variables such as marital status have differing associations with different OCD outcomes makes good sense; OCD typically begins by early adulthood (so OCD onset is associated with being unmarried), OCD negatively impacts relationships (so severe OCD is associated with no longer being married), and where an individual with OCD is married a concerned spouse may insist on treatment (so lower rates of treatment are associated with never being married).</p><p id="Par57">Our finding that OCD is often accompanied by comorbid mental disorders is consistent with previous clinical and epidemiological work [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. Temporal patterns may reflect typical age of disorder onset, such as the very early onset of ADHD, and may point to specific causal pathways, such as the use of alcohol to decrease anxiety symptoms. Our finding that temporally prior comorbid disorders share different associations with OCD onset, persistence, severity, and treatment is novel, underscoring the clinical importance of evaluating comorbidity, and suggesting future research directions [<xref ref-type="bibr" rid="CR54">54</xref>]. The relationship between OCD and alcohol use, for example, is not well studied, and our finding that alcohol use disorder is positively associated with OCD persistence points to the need for clinical and research attention to this issue [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. Conversely, our finding that panic disorder predicts a less persistent course of OCD could be due to the association of panic disorder with treatment seeking [<xref ref-type="bibr" rid="CR57">57</xref>]. Unexpectedly, temporally prior social phobia was the most consistent predictor of OCD-related outcomes. Whether social phobia is a marker for shared risk factors (e.g., behavioral inhibition; overactive performance monitoring) [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>], creates conditions that exacerbate OCD symptoms (e.g., social isolation) [<xref ref-type="bibr" rid="CR60">60</xref>], or contributes directly to OCD onset, severity, and treatment seeking warrants further attention to inform the development of preventive interventions.</p></sec><sec id="Sec19"><title>Conclusions</title><p id="Par58">Taken together, these data comprise the largest cross-national epidemiological study of OCD to date. Across the 10 countries included here, OCD emerges early in life, is highly persistent, and is undertreated, emphasizing the public health significance of this often-overlooked condition. At the same time, OCD is more prevalent, more persistent, less severe, and far less likely to receive treatment in LMICs than HICs, arguing for caution when generalizing research findings from HICs to LMICs. OCD has received comparatively little attention in global mental health, and further cross-national research is needed on optimal diagnostic approaches, barriers to treatment, efficacy of treatments delivered by non-specialist community health workers, and implementation of evidence-based interventions in under-resourced settings [<xref ref-type="bibr" rid="CR61">61</xref>&#x02013;<xref ref-type="bibr" rid="CR64">64</xref>]. Research is also needed on modifiable risk factors that transcend country boundaries. Given the specificity of risk factors for OCD onset, course, severity, and treatment, each of these outcomes should be studied separately to yield more precise etiological models and intervention targets.</p></sec><sec id="Sec20" sec-type="supplementary-material"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12916_2025_4209_MOESM1_ESM.docx"><caption><p>Additional file 1. Appendix Table 1. World Mental Health (WMH) sample characteristics by World Bank income categories. Appendix Table 2. Prevalence of OCD Symptom Dimensions in the World Mental Health surveys. Appendix Table 3. Univariate associations of temporally prior lifetime disorders with subsequent <italic>DSM-IV</italic> OCD onset, persistence, severity, and treatment.</p></caption></media></supplementary-material></p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ADHD</term><def><p id="Par5">Attention-deficit/hyperactivity disorder</p></def></def-item><def-item><term>CIDI 3.0</term><def><p id="Par6">Composite International Diagnostic Interview Version 3.0</p></def></def-item><def-item><term>CIDI</term><def><p id="Par7">Composite International Diagnostic Interview</p></def></def-item><def-item><term>CIs</term><def><p id="Par8">Confidence intervals</p></def></def-item><def-item><term>DIS</term><def><p id="Par9">Diagnostic Interview Schedule</p></def></def-item><def-item><term><italic>DSM</italic></term><def><p id="Par10">Diagnostic and Statistical Manual of Mental Disorders</p></def></def-item><def-item><term>ECA</term><def><p id="Par11">Epidemiological Catchment Area</p></def></def-item><def-item><term>HICs</term><def><p id="Par12">High-income countries </p></def></def-item><def-item><term>LMICs</term><def><p id="Par13">Low- or middle-income countries</p></def></def-item><def-item><term>NCS-R</term><def><p id="Par14">National Comorbidity Survey Replication</p></def></def-item><def-item><term>O/C</term><def><p id="Par15">Obsessions and compulsions</p></def></def-item><def-item><term>OCD</term><def><p id="Par16">Obsessive-compulsive disorder</p></def></def-item><def-item><term>ORs</term><def><p id="Par17">Odds ratios</p></def></def-item><def-item><term>SCID</term><def><p id="Par18">Structured Clinical Interview for <italic>DSM-IV</italic>
</p></def></def-item><def-item><term>WEIRD</term><def><p id="Par19">Western, Educated, Industrialized, Rich, and Democratic</p></def></def-item><def-item><term>WMH</term><def><p id="Par20">World Mental Health</p></def></def-item><def-item><term>Y-BOCS</term><def><p id="Par21">Yale-Brown Obsessive-Compulsive Scale</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Dan J. Stein and Ayelet Meron Ruscio contributed equally to this work.</p></fn></fn-group><ack><title>Acknowledgements
</title><p>The World Mental Health Survey collaborators are Sergio Aguilar-Gaxiola, MD, PhD; Ali Al-Hamzawi, MD; Jordi Alonso, MD, PhD; Yasmin A. Altwaijri, PhD; Laura Helena Andrade, MD, PhD; Lukoye Atwoli, MD, PhD; Corina Benjet, PhD; Guilherme Borges, ScD;; Ronny Bruffaerts, PhD; Brendan Bunting, PhD; Jose Miguel Caldas-de-Almeida, MD, PhD; Gra&#x000e7;a Cardoso, MD, PhD; Stephanie Chardoul, BA;; Louisa Degenhardt, PhD; Giovanni de Girolamo, MD; Oye Gureje, MD, DSc, FRCPsych; Josep Maria Haro, MD, PhD; Meredith G. Harris, PhD; Hristo Hinkov, MD, PhD; Chiyi Hu, MD, PhD; Peter de Jonge, PhD; Aimee Nasser Karam, PhD; Elie G. Karam, MD; Georges Karam, MD; Alan E. Kazdin, PhD; Norito Kawakami, MD, DMSc; Ronald C. Kessler, PhD; Andrzej Kiejna, MD, PhD; Viviane Kovess-Masfety, MD, PhD; John J. McGrath, MD, PhD; Maria Elena Medina-Mora, PhD; Jacek Moskalewicz, PhD; Fernando Navarro-Mateu, MD, PhD; Daisuke Nishi, MD, PhD; Marina Piazza, MPH, ScD; Jos&#x000e9; Posada-Villa, MD; Annelieke Roest, PhD; Kate M. Scott, PhD; Juan Carlos Stagnaro, MD, PhD; Dan J. Stein, FRCPC, PhD; Margreet ten Have, PhD; Nathan Tintle, PhD; Maria Carmen Viana, MD, PhD; Daniel V. Vigo, MD, DrPH; Cristian Vladescu, MD, PhD;; David R. Williams, MPH, PhD; Bogdan Wojtyniak, ScD; Miguel Xavier, MD, PhD; Alan M. Zaslavsky, PhD.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions
</title><p>D.J.S. and A.M.R. conceptualized the study. D.J.S., A.M.R., and R.C.K. designed the study. D.J.S., Y.A., W.T.C., N.A.S., S-A.G., A-A.H., J.A., S.C., O.G., C.H., E.G.K., J.J.M., F-N.M., K.M.S., J.C.S., C.V., J.W., M.X., Y.T., and R.C.K. acquired and analyzed the data. D.J.S., A.M.R., N.A.S., and R.C.K. interpreted the data. W.T.C. and N.A.S. created new software used in the work. D.J.S., A.M.R., Y.A., W.T.C., N.A.S., S-A.G., A-A.H., J.A., S.C., O.G., C.H., E.G.K., J.J.M., F-N.M., K.M.S., J.C.S., C.V., J.W., M.X., Y.T., and R.C.K. drafted the work or substantively revised it. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>The World Mental Health (WMH) Survey Initiative is supported by the National Institute of Mental Health (NIMH; R01 MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical, Inc., GlaxoSmithKline, and Bristol-Myers Squibb. We thank the staff of the WMH Data Collection and Data Analysis Coordination Centres for assistance with instrumentation, fieldwork, and consultation on data analysis.</p><p>The Argentina survey, Estudio Argentino de Epidemiolog&#x000ed;a en Salud Mental (EASM), was supported by a grant from the Argentinian Ministry of Health (Ministerio de Salud de la Naci&#x000f3;n), (Grant Number 2002-17270/13-5). The 2007 Australian National Survey of Mental Health and Wellbeing was funded by the Australian Government Department of Health and Ageing. The Shenzhen Mental Health Survey is supported by the Shenzhen Bureau of Health and the Shenzhen Bureau of Science, Technology, and Information. The Mental Health Study Medell&#x000ed;n, Colombia, was carried out and supported jointly by the Center for Excellence on Research in Mental Health (CES University) and the Secretary of Health of Medell&#x000ed;n. Implementation of the Iraq Mental Health Survey (IMHS) and data entry were carried out by the staff of the Iraqi Ministry of Health and Ministry of Planning with direct support from the Iraqi IMHS team with funding from both the Japanese and European Funds through United Nations Development Group Iraq Trust Fund (UNDG ITF). The Polish project Epidemiology of Mental Health and Access to Care, EZOP 2, was carried out by the Institute of Psychiatry and Neurology, Warsaw in collaboration with colleagues from the National Institute of Public Health &#x02013; National Institute of Hygiene, Warsaw and was entirely funded by the Polish Ministry of Health. The Portuguese Mental Health Study was carried out by the Department of Mental Health, Faculty of Medical Sciences, NOVA University of Lisbon, with collaboration of the Portuguese Catholic University, and was funded by Champalimaud Foundation, Gulbenkian Foundation, Foundation for Science and Technology (FCT) and the Portuguese Ministry of Health. The Romania WMH study projects &#x0201c;Policies in Mental Health Area&#x0201d; and &#x0201c;National Study regarding Mental Health and Services Use&#x0201d; were carried out by National School of Public Health &#x00026; Health Services Management (present National School of Public Health Management &#x00026; Professional Development, Bucharest), with technical support of Metro Media Transilvania, the National Institute of Statistics, SC Cheyenne Services SRL, and Statistics Netherlands. Funding was provided by the Ministry of Public Health with supplemental support of Eli Lilly Romania SRL. The Saudi National Mental Health Survey (SNMHS) is conducted by the King Salman Center for Disability Research. It is funded by Saudi Basic Industries Corporation (SABIC), King Abdulaziz City for Science and Technology (KACST), the Ministry of Health (Saudi Arabia), and King Saud University. Funding in-kind was provided by King Faisal Specialist Hospital and Research Center, and the Ministry of Economy and Planning, General Authority for Statistics. The Psychiatric Enquiry to General Population in Southeast Spain &#x02013; Murcia (PEGASUS-Murcia) Project has been financed by the Regional Health Authorities of Murcia (Servicio Murciano de Salud and Consejer&#x000ed;a de Sanidad y Pol&#x000ed;tica Social) and Fundaci&#x000f3;n para la Formaci&#x000f3;n e Investigaci&#x000f3;n Sanitarias (FFIS) of Murcia.</p><p>None of the funders had any role in the design, analysis, interpretation of results, or preparation of this paper. A complete list of all within-country and cross-national WMH publications can be found at&#x000a0;<ext-link ext-link-type="uri" xlink:href="http://www.hcp.med.harvard.edu/wmh/">http://www.hcp.med.harvard.edu/wmh/</ext-link>.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>Access to the cross-national World Mental Health (WMH) data is governed by the organizations funding and responsible for survey data collection in each country. These organizations made data available to the WMH consortium through restricted data sharing agreements that do not allow us to release the data to third parties. The exception is that the U.S. data are available for secondary analysis [<xref ref-type="bibr" rid="CR65">65</xref>].</p></notes><notes><title>Declarations</title><notes id="FPar2"><title>Ethics approval and consent to participate</title><p id="Par59">At all survey sites, the local ethics or institutional review committee reviewed and approved the protocol to ensure protection of human subjects, in line with appropriate international and local guidelines. Details of the ethics committees for the WMH surveys can be viewed at this link:&#x000a0;<ext-link ext-link-type="uri" xlink:href="http://www.hcp.med.harvard.edu/wmh/ftpdir/WMH_Ethics_approval.pdf">http://www.hcp.med.harvard.edu/wmh/ftpdir/WMH_Ethics_approval.pdf</ext-link>.</p></notes><notes id="FPar3"><title>Consent for publication</title><p id="Par60">Not applicable.</p></notes><notes id="FPar4" notes-type="COI-statement"><title>Competing interests</title><p id="Par61">In the past 3 years, Dr. Kessler was a consultant for Cambridge Health Alliance, Canandaigua VA Medical Center, Child Mind Institute, Holmusk, Massachusetts General Hospital, Partners Healthcare, Inc., RallyPoint Networks, Inc., Sage Therapeutics and University of North Carolina. He has stock options in Cerebral Inc., Mirah, PYM (Prepare Your Mind), Roga Sciences and Verisense Health. Dr. Stein has received consultancy honoraria from Discovery Vitality, Johnson &#x00026; Johnson, Kanna, L&#x02019;Oreal, Lundbeck, Orion, Servier, Seaport Therapeutics, Takeda, Vistagen, and Wellcome. All other authors report no conflicts of interest related to this manuscript.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Fontenelle</surname><given-names>LF</given-names></name><name><surname>Mendlowicz</surname><given-names>MV</given-names></name><name><surname>Versiani</surname><given-names>M</given-names></name></person-group><article-title>The descriptive epidemiology of obsessive-compulsive disorder</article-title><source>Prog Neuropsychopharmacol Biol Psychiatry</source><year>2006</year><volume>30</volume><fpage>327</fpage><lpage>337</lpage><?supplied-pmid 16412548?><pub-id pub-id-type="pmid">16412548</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Fontenelle LF, Mendlowicz MV, Versiani M. The descriptive epidemiology of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:327&#x02013;37.<pub-id pub-id-type="pmid">16412548</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Judd</surname><given-names>LL</given-names></name></person-group><article-title>Obsessive compulsive neurosis in children</article-title><source>Arch Gen Psychiatry</source><year>1965</year><volume>12</volume><fpage>136</fpage><lpage>143</lpage><?supplied-pmid 14237623?><pub-id pub-id-type="pmid">14237623</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Judd LL. Obsessive compulsive neurosis in children. Arch Gen Psychiatry. 1965;12:136&#x02013;43.<pub-id pub-id-type="pmid">14237623</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Karno</surname><given-names>M</given-names></name><name><surname>Golding</surname><given-names>JM</given-names></name><name><surname>Sorenson</surname><given-names>SB</given-names></name><name><surname>Burnam</surname><given-names>MA</given-names></name></person-group><article-title>The epidemiology of obsessive-compulsive disorder in five US communities</article-title><source>Arch Gen Psychiatry</source><year>1988</year><volume>45</volume><fpage>1094</fpage><lpage>1099</lpage><?supplied-pmid 3264144?><pub-id pub-id-type="pmid">3264144</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Karno M, Golding JM, Sorenson SB, Burnam MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry. 1988;45:1094&#x02013;9.<pub-id pub-id-type="pmid">3264144</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Horwath</surname><given-names>E</given-names></name><name><surname>Weissman</surname><given-names>MM</given-names></name></person-group><article-title>The epidemiology and cross-national presentation of obsessive-compulsive disorder</article-title><source>Psychiatr Clin North Am</source><year>2000</year><volume>23</volume><fpage>493</fpage><lpage>507</lpage><?supplied-pmid 10986723?><pub-id pub-id-type="pmid">10986723</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Horwath E, Weissman MM. The epidemiology and cross-national presentation of obsessive-compulsive disorder. Psychiatr Clin North Am. 2000;23:493&#x02013;507.<pub-id pub-id-type="pmid">10986723</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>RC</given-names></name><name><surname>Ust&#x000fc;n</surname><given-names>TB</given-names></name></person-group><article-title>The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI)</article-title><source>Int J Methods Psychiatr Res</source><year>2004</year><volume>13</volume><fpage>93</fpage><lpage>121</lpage><?supplied-pmid 15297906?><pub-id pub-id-type="pmid">15297906</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Kessler RC, Ust&#x000fc;n TB. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res. 2004;13:93&#x02013;121.<pub-id pub-id-type="pmid">15297906</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Ruscio</surname><given-names>AM</given-names></name><name><surname>Stein</surname><given-names>DJ</given-names></name><name><surname>Chiu</surname><given-names>WT</given-names></name><name><surname>Kessler</surname><given-names>RC</given-names></name></person-group><article-title>The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication</article-title><source>Mol Psychiatry</source><year>2010</year><volume>15</volume><fpage>53</fpage><lpage>63</lpage><?supplied-pmid 18725912?><pub-id pub-id-type="pmid">18725912</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15:53&#x02013;63.<pub-id pub-id-type="pmid">18725912</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Fontenelle</surname><given-names>LF</given-names></name><name><surname>Hasler</surname><given-names>G</given-names></name></person-group><article-title>The analytical epidemiology of obsessive-compulsive disorder: risk factors and correlates</article-title><source>Prog Neuropsychopharmacol Biol Psychiatry</source><year>2008</year><volume>32</volume><fpage>1</fpage><lpage>15</lpage><?supplied-pmid 17689849?><pub-id pub-id-type="pmid">17689849</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Fontenelle LF, Hasler G. The analytical epidemiology of obsessive-compulsive disorder: risk factors and correlates. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1&#x02013;15.<pub-id pub-id-type="pmid">17689849</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Fawcett</surname><given-names>EJ</given-names></name><name><surname>Power</surname><given-names>H</given-names></name><name><surname>Fawcett</surname><given-names>JM</given-names></name></person-group><article-title>Women are at greater risk of OCD than men: a meta-analytic review of OCD prevalence worldwide</article-title><source>J Clin Psychiatry.</source><year>2020</year><volume>81</volume><fpage>19r13085</fpage><?supplied-pmid 32603559?><pub-id pub-id-type="pmid">32603559</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Fawcett EJ, Power H, Fawcett JM. Women are at greater risk of OCD than men: a meta-analytic review of OCD prevalence worldwide. J Clin Psychiatry. 2020;81:19r13085.<pub-id pub-id-type="pmid">32603559</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Henrich</surname><given-names>J</given-names></name><name><surname>Heine</surname><given-names>SJ</given-names></name><name><surname>Norenzayan</surname><given-names>A</given-names></name></person-group><article-title>The weirdest people in the world?</article-title><source>Behav Brain Sci.</source><year>2010</year><volume>33</volume><fpage>61</fpage><lpage>83</lpage><?supplied-pmid 20550733?><pub-id pub-id-type="pmid">20550733</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Henrich J, Heine SJ, Norenzayan A. The weirdest people in the world? Behav Brain Sci. 2010;33:61&#x02013;83 discussion -135.<pub-id pub-id-type="pmid">20550733</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Foa</surname><given-names>EB</given-names></name><name><surname>Kozak</surname><given-names>MJ</given-names></name><name><surname>Goodman</surname><given-names>WK</given-names></name><name><surname>Hollander</surname><given-names>E</given-names></name><name><surname>Jenike</surname><given-names>MA</given-names></name><name><surname>Rasmussen</surname><given-names>SA</given-names></name></person-group><article-title>DSM-IV field trial: obsessive-compulsive disorder</article-title><source>Am J Psychiatry</source><year>1995</year><volume>152</volume><fpage>90</fpage><lpage>96</lpage><?supplied-pmid 7802127?><pub-id pub-id-type="pmid">7802127</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Foa EB, Kozak MJ, Goodman WK, Hollander E, Jenike MA, Rasmussen SA. DSM-IV field trial: obsessive-compulsive disorder. Am J Psychiatry. 1995;152:90&#x02013;6.<pub-id pub-id-type="pmid">7802127</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Van Ameringen</surname><given-names>M</given-names></name><name><surname>Patterson</surname><given-names>B</given-names></name><name><surname>Simpson</surname><given-names>W</given-names></name></person-group><article-title>DSM-5 obsessive-compulsive and related disorders: clinical implications of new criteria</article-title><source>Depress Anxiety</source><year>2014</year><volume>31</volume><fpage>487</fpage><lpage>493</lpage><?supplied-pmid 24616177?><pub-id pub-id-type="pmid">24616177</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Van Ameringen M, Patterson B, Simpson W. DSM-5 obsessive-compulsive and related disorders: clinical implications of new criteria. Depress Anxiety. 2014;31:487&#x02013;93.<pub-id pub-id-type="pmid">24616177</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis-Fern&#x000e1;ndez</surname><given-names>R</given-names></name><name><surname>Hinton</surname><given-names>DE</given-names></name><name><surname>Laria</surname><given-names>AJ</given-names></name><name><surname>Patterson</surname><given-names>EH</given-names></name><name><surname>Hofmann</surname><given-names>SG</given-names></name><name><surname>Craske</surname><given-names>MG</given-names></name><etal/></person-group><article-title>Culture and the anxiety disorders: recommendations for DSM-V</article-title><source>Depress Anxiety</source><year>2010</year><volume>27</volume><fpage>212</fpage><lpage>229</lpage><?supplied-pmid 20037918?><pub-id pub-id-type="pmid">20037918</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Lewis-Fern&#x000e1;ndez R, Hinton DE, Laria AJ, Patterson EH, Hofmann SG, Craske MG, et al. Culture and the anxiety disorders: recommendations for DSM-V. Depress Anxiety. 2010;27:212&#x02013;29.<pub-id pub-id-type="pmid">20037918</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Kraemer</surname><given-names>HC</given-names></name><name><surname>Kazdin</surname><given-names>AE</given-names></name><name><surname>Offord</surname><given-names>DR</given-names></name><name><surname>Kessler</surname><given-names>RC</given-names></name><name><surname>Jensen</surname><given-names>PS</given-names></name><name><surname>Kupfer</surname><given-names>DJ</given-names></name></person-group><article-title>Coming to terms with the terms of risk</article-title><source>Arch Gen Psychiatry</source><year>1997</year><volume>54</volume><fpage>337</fpage><lpage>343</lpage><?supplied-pmid 9107150?><pub-id pub-id-type="pmid">9107150</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Kraemer HC, Kazdin AE, Offord DR, Kessler RC, Jensen PS, Kupfer DJ. Coming to terms with the terms of risk. Arch Gen Psychiatry. 1997;54:337&#x02013;43.<pub-id pub-id-type="pmid">9107150</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="book"><person-group person-group-type="author"><collab>Scott KM, de Jonge P, Stein DJ, Kessler RC. Mental disorders around the world: Facts and figures from the WHO World Mental Health surveys</collab></person-group><source>New York</source><year>2017</year><publisher-loc>NY</publisher-loc><publisher-name>Cambridge University Press</publisher-name></element-citation><mixed-citation id="mc-CR14" publication-type="book">Scott KM, de Jonge P, Stein DJ, Kessler RC. Mental disorders around the world: Facts and figures from the WHO World Mental Health surveys. New York. NY: Cambridge University Press; 2017.</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Kessler RC, Heeringa SG, Pennell BE, Sampson NA, Zaslavsky AM. Methods of the World Mental Health Surveys. In: Mental disorders around the world: Facts and figures from the WHO World Mental Health surveys. 2017. Cambridge University Press; New York, NY.</mixed-citation></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="book"><person-group person-group-type="author"><name><surname>Harkness</surname><given-names>J</given-names></name><name><surname>Pennell</surname><given-names>B</given-names></name><name><surname>Villar</surname><given-names>A</given-names></name><name><surname>Gebler</surname><given-names>N</given-names></name><name><surname>Aguilar-Gaxiola</surname><given-names>S</given-names></name><name><surname>Bilgen</surname><given-names>I</given-names></name></person-group><article-title>Translation procedures and translation assessment in the World Mental Health Survey Initiative</article-title><source>The WHO World Mental Health Surveys: Global Perspectives on the Epidemiology of Mental Disorders</source><year>2008</year><publisher-loc>NY</publisher-loc><publisher-name>Cambridge University Press; New York</publisher-name><fpage>91</fpage><lpage>113</lpage></element-citation><mixed-citation id="mc-CR16" publication-type="book">Harkness J, Pennell B, Villar A, Gebler N, Aguilar-Gaxiola S, Bilgen I. Translation procedures and translation assessment in the World Mental Health Survey Initiative. In: The WHO World Mental Health Surveys: Global Perspectives on the Epidemiology of Mental Disorders. NY: Cambridge University Press; New York; 2008. p. 91&#x02013;113.</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="other">Pennell B, Mneimneh ZN, Bowers A, Chardoul S, Wells JE, Viana CV, et al. Implementation of the World Mental Health Surveys. In: The WHO World Mental Health Surveys:Global Perspectives on the Epidemiology of Mental Disorders. 2008. Cambridge University Press: New York, NY.</mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="other">First MB, Spitzer RL, Gibbon M, Williams JB. Structured clinical interview for DSM-IV Axis I Disorders: Washington: American Psychiatric Press; 1997.</mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">Harvard Medical School. National Comorbidity Survey (NCS). 2005. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.hcp.med.harvard.edu/ncs">www.hcp.med.harvard.edu/ncs</ext-link>.&#x000a0;Cited 2025 Feb 13.</mixed-citation></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Goodman</surname><given-names>WK</given-names></name><name><surname>Price</surname><given-names>LH</given-names></name><name><surname>Rasmussen</surname><given-names>SA</given-names></name><name><surname>Mazure</surname><given-names>C</given-names></name><name><surname>Fleischmann</surname><given-names>RL</given-names></name><name><surname>Hill</surname><given-names>CL</given-names></name><etal/></person-group><article-title>The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability</article-title><source>Arch Gen Psychiatry.</source><year>1989</year><volume>46</volume><fpage>1006</fpage><lpage>11</lpage><?supplied-pmid 2684084?><pub-id pub-id-type="pmid">2684084</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46:1006&#x02013;11.<pub-id pub-id-type="pmid">2684084</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Federici</surname><given-names>A</given-names></name><name><surname>Summerfeldt</surname><given-names>LJ</given-names></name><name><surname>Harrington</surname><given-names>JL</given-names></name><name><surname>McCabe</surname><given-names>RE</given-names></name><name><surname>Purdon</surname><given-names>CL</given-names></name><name><surname>Rowa</surname><given-names>K</given-names></name><etal/></person-group><article-title>Consistency between self-report and clinician-administered versions of the Yale-Brown Obsessive-Compulsive Scale</article-title><source>J Anxiety Disord</source><year>2010</year><volume>24</volume><fpage>729</fpage><lpage>733</lpage><?supplied-pmid 20561767?><pub-id pub-id-type="pmid">20561767</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Federici A, Summerfeldt LJ, Harrington JL, McCabe RE, Purdon CL, Rowa K, et al. Consistency between self-report and clinician-administered versions of the Yale-Brown Obsessive-Compulsive Scale. J Anxiety Disord. 2010;24:729&#x02013;33.<pub-id pub-id-type="pmid">20561767</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Ghimire</surname><given-names>DJ</given-names></name><name><surname>Chardoul</surname><given-names>S</given-names></name><name><surname>Kessler</surname><given-names>RC</given-names></name><name><surname>Axinn</surname><given-names>WG</given-names></name><name><surname>Adhikari</surname><given-names>BP</given-names></name></person-group><article-title>Modifying and validating the Composite International Diagnostic Interview (CIDI) for use in Nepal</article-title><source>Int J Methods Psychiatr Res</source><year>2013</year><volume>22</volume><fpage>71</fpage><lpage>81</lpage><?supplied-pmid 23494758?><pub-id pub-id-type="pmid">23494758</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Ghimire DJ, Chardoul S, Kessler RC, Axinn WG, Adhikari BP. Modifying and validating the Composite International Diagnostic Interview (CIDI) for use in Nepal. Int J Methods Psychiatr Res. 2013;22:71&#x02013;81.<pub-id pub-id-type="pmid">23494758</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>YQ</given-names></name><name><surname>Liu</surname><given-names>ZR</given-names></name><name><surname>Cao</surname><given-names>XL</given-names></name></person-group><article-title>Validity of Chinese version of the Composite International Diagnostic Interview-3.0 in psychiatric Settings</article-title><source>Chin Med J (Engl).</source><year>2015</year><volume>128</volume><fpage>2462</fpage><lpage>6</lpage><?supplied-pmid 26365963?><pub-id pub-id-type="pmid">26365963</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Lu J, Huang YQ, Liu ZR, Cao XL. Validity of Chinese version of the Composite International Diagnostic Interview-3.0 in psychiatric Settings. Chin Med J (Engl). 2015;128:2462&#x02013;6.<pub-id pub-id-type="pmid">26365963</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Haro</surname><given-names>JM</given-names></name><name><surname>Arbabzadeh-Bouchez</surname><given-names>S</given-names></name><name><surname>Brugha</surname><given-names>TS</given-names></name><name><surname>de Girolamo</surname><given-names>G</given-names></name><name><surname>Guyer</surname><given-names>ME</given-names></name><name><surname>Jin</surname><given-names>R</given-names></name><etal/></person-group><article-title>Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys</article-title><source>Int J Methods Psychiatr Res.</source><year>2006</year><volume>15</volume><fpage>167</fpage><lpage>80</lpage><?supplied-pmid 17266013?><pub-id pub-id-type="pmid">17266013</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Haro JM, Arbabzadeh-Bouchez S, Brugha TS, de Girolamo G, Guyer ME, Jin R, et al. Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. Int J Methods Psychiatr Res. 2006;15:167&#x02013;80.<pub-id pub-id-type="pmid">17266013</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Montoya Gonzalez</surname><given-names>LE</given-names></name><name><surname>Restrepo Bernal</surname><given-names>DP</given-names></name><name><surname>Mej&#x000ed;a-Montoya</surname><given-names>R</given-names></name><name><surname>Bare&#x000f1;o-Silva</surname><given-names>J</given-names></name><name><surname>Sierra-Hincapi&#x000e9;</surname><given-names>G</given-names></name><name><surname>Torres de Galvis</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Sensitivity and specificity between the Composite International Diagnostic Interview Version 3.0 (World Mental Health, CIDI) and the Standardised Clinical Evaluation version I (SCID-I) in a mental health survey of the city of Medellin, 2012</article-title><source>Rev Colomb Psiquiatr.</source><year>2016</year><volume>45</volume><fpage>22</fpage><lpage>7</lpage><?supplied-pmid 26896401?><pub-id pub-id-type="pmid">26896401</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Montoya Gonzalez LE, Restrepo Bernal DP, Mej&#x000ed;a-Montoya R, Bare&#x000f1;o-Silva J, Sierra-Hincapi&#x000e9; G, Torres de Galvis Y, et al. Sensitivity and specificity between the Composite International Diagnostic Interview Version 3.0 (World Mental Health, CIDI) and the Standardised Clinical Evaluation version I (SCID-I) in a mental health survey of the city of Medellin, 2012. Rev Colomb Psiquiatr. 2016;45:22&#x02013;7.<pub-id pub-id-type="pmid">26896401</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>RC</given-names></name><name><surname>Al-Desouki</surname><given-names>M</given-names></name><name><surname>King</surname><given-names>AJ</given-names></name><name><surname>Sampson</surname><given-names>NA</given-names></name><name><surname>Al-Subaie</surname><given-names>AS</given-names></name><name><surname>Al-Habeeb</surname><given-names>A</given-names></name><etal/></person-group><article-title>Clinical reappraisal of the Composite International Diagnostic Interview Version 3.0 in the Saudi National Mental Health Survey</article-title><source>Int J Methods Psychiatr Res.</source><year>2020</year><volume>29</volume><fpage>e1828</fpage><?supplied-pmid 33245606?><pub-id pub-id-type="pmid">33245606</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Kessler RC, Al-Desouki M, King AJ, Sampson NA, Al-Subaie AS, Al-Habeeb A, et al. Clinical reappraisal of the Composite International Diagnostic Interview Version 3.0 in the Saudi National Mental Health Survey. Int J Methods Psychiatr Res. 2020;29:e1828.<pub-id pub-id-type="pmid">33245606</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>RC</given-names></name><name><surname>Abelson</surname><given-names>J</given-names></name><name><surname>Demler</surname><given-names>O</given-names></name><name><surname>Escobar</surname><given-names>JI</given-names></name><name><surname>Gibbon</surname><given-names>M</given-names></name><name><surname>Guyer</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMHCIDI)</article-title><source>Int J Methods Psychiatr Res</source><year>2004</year><volume>13</volume><fpage>122</fpage><lpage>139</lpage><?supplied-pmid 15297907?><pub-id pub-id-type="pmid">15297907</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Kessler RC, Abelson J, Demler O, Escobar JI, Gibbon M, Guyer ME, et al. Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMHCIDI). Int J Methods Psychiatr Res. 2004;13:122&#x02013;39.<pub-id pub-id-type="pmid">15297907</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>McGrath</surname><given-names>JJ</given-names></name><name><surname>Al-Hamzawi</surname><given-names>A</given-names></name><name><surname>Alonso</surname><given-names>J</given-names></name><name><surname>Altwaijri</surname><given-names>Y</given-names></name><name><surname>Andrade</surname><given-names>LH</given-names></name><name><surname>Bromet</surname><given-names>EJ</given-names></name><etal/></person-group><article-title>Age of onset and cumulative risk of mental disorders: a cross-national analysis of population surveys from 29 countries</article-title><source>Lancet Psychiatry</source><year>2023</year><volume>10</volume><fpage>668</fpage><lpage>681</lpage><?supplied-pmid 37531964?><pub-id pub-id-type="pmid">37531964</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">McGrath JJ, Al-Hamzawi A, Alonso J, Altwaijri Y, Andrade LH, Bromet EJ, et al. Age of onset and cumulative risk of mental disorders: a cross-national analysis of population surveys from 29 countries. Lancet Psychiatry. 2023;10:668&#x02013;81.<pub-id pub-id-type="pmid">37531964</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="other">SAS Institute Inc. SAS &#x000ae;Software 9.4 In (Version 9.4) 2013.</mixed-citation></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>JD</given-names></name><name><surname>Willett</surname><given-names>JB</given-names></name></person-group><article-title>It&#x02019;s about time: using discrete-time survival analysis to study duration and the timing of events</article-title><source>J Educ Stat</source><year>1993</year><volume>18</volume><fpage>155</fpage><lpage>195</lpage></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Singer JD, Willett JB. It&#x02019;s about time: using discrete-time survival analysis to study duration and the timing of events. J Educ Stat. 1993;18:155&#x02013;95.</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>E</given-names></name><name><surname>Rice</surname><given-names>J</given-names></name></person-group><article-title>Stability of diagnosis of obsessive-compulsive disorder in the Epidemiologic Catchment Area study</article-title><source>Am J Psychiatry</source><year>1997</year><volume>154</volume><fpage>826</fpage><lpage>831</lpage><?supplied-pmid 9167511?><pub-id pub-id-type="pmid">9167511</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Nelson E, Rice J. Stability of diagnosis of obsessive-compulsive disorder in the Epidemiologic Catchment Area study. Am J Psychiatry. 1997;154:826&#x02013;31.<pub-id pub-id-type="pmid">9167511</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>MB</given-names></name><name><surname>Forde</surname><given-names>DR</given-names></name><name><surname>Anderson</surname><given-names>G</given-names></name><name><surname>Walker</surname><given-names>JR</given-names></name></person-group><article-title>Obsessive-compulsive disorder in the community: an epidemiologic survey with clinical reappraisal</article-title><source>Am J Psychiatry</source><year>1997</year><volume>154</volume><fpage>1120</fpage><lpage>1126</lpage><?supplied-pmid 9247399?><pub-id pub-id-type="pmid">9247399</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Stein MB, Forde DR, Anderson G, Walker JR. Obsessive-compulsive disorder in the community: an epidemiologic survey with clinical reappraisal. Am J Psychiatry. 1997;154:1120&#x02013;6.<pub-id pub-id-type="pmid">9247399</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Chavira</surname><given-names>DA</given-names></name><name><surname>Garrido</surname><given-names>H</given-names></name><name><surname>Bagnarello</surname><given-names>M</given-names></name><name><surname>Azzam</surname><given-names>A</given-names></name><name><surname>Reus</surname><given-names>VI</given-names></name><name><surname>Mathews</surname><given-names>CA</given-names></name></person-group><article-title>A comparative study of obsessive-compulsive disorder in Costa Rica and the United States</article-title><source>Depress Anxiety</source><year>2008</year><volume>25</volume><fpage>609</fpage><lpage>619</lpage><?supplied-pmid 17823962?><pub-id pub-id-type="pmid">17823962</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Chavira DA, Garrido H, Bagnarello M, Azzam A, Reus VI, Mathews CA. A comparative study of obsessive-compulsive disorder in Costa Rica and the United States. Depress Anxiety. 2008;25:609&#x02013;19.<pub-id pub-id-type="pmid">17823962</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Altwaijri</surname><given-names>Y</given-names></name><name><surname>Stein</surname><given-names>DJ</given-names></name><name><surname>Akkad</surname><given-names>M</given-names></name><name><surname>Bilal</surname><given-names>L</given-names></name><name><surname>Talal Naseem</surname><given-names>M</given-names></name><name><surname>Al-Subaie</surname><given-names>A</given-names></name><etal/></person-group><article-title>The epidemiology of obsessive-compulsive disorder in the Kingdom of Saudi Arabia: data from the Saudi National Mental Health Survey</article-title><source>J Anxiety Disord</source><year>2024</year><volume>103</volume><fpage>102856</fpage><?supplied-pmid 38554604?><pub-id pub-id-type="pmid">38554604</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Altwaijri Y, Stein DJ, Akkad M, Bilal L, Talal Naseem M, Al-Subaie A, et al. The epidemiology of obsessive-compulsive disorder in the Kingdom of Saudi Arabia: data from the Saudi National Mental Health Survey. J Anxiety Disord. 2024;103: 102856.<pub-id pub-id-type="pmid">38554604</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>C</given-names></name></person-group><article-title>Differences in OCD symptom presentations across age, culture, and gender: a quantitative review of studies using the Y-BOCS symptom checklist</article-title><source>J Obsessive Compuls Relat Disord</source><year>2020</year><volume>26</volume><fpage>100533</fpage></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Hunt C. Differences in OCD symptom presentations across age, culture, and gender: a quantitative review of studies using the Y-BOCS symptom checklist. J Obsessive Compuls Relat Disord. 2020;26: 100533.</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>DJ</given-names></name><name><surname>Rapoport</surname><given-names>JL</given-names></name></person-group><article-title>Cross-cultural studies and obsessive-compulsive disorder</article-title><source>CNS Spectr</source><year>1996</year><volume>1</volume><fpage>42</fpage><lpage>46</lpage></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Stein DJ, Rapoport JL. Cross-cultural studies and obsessive-compulsive disorder. CNS Spectr. 1996;1:42&#x02013;6.</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Kn&#x000e4;uper</surname><given-names>B</given-names></name><name><surname>Cannell</surname><given-names>CF</given-names></name><name><surname>Schwarz</surname><given-names>N</given-names></name><name><surname>Bruce</surname><given-names>ML</given-names></name><name><surname>Kessler</surname><given-names>RC</given-names></name></person-group><article-title>Improving accuracy of major depression age-of-onset reports in the US National Comorbidity Survey</article-title><source>Int J Methods Psychiatr Res</source><year>1999</year><volume>8</volume><fpage>39</fpage><lpage>48</lpage></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Kn&#x000e4;uper B, Cannell CF, Schwarz N, Bruce ML, Kessler RC. Improving accuracy of major depression age-of-onset reports in the US National Comorbidity Survey. Int J Methods Psychiatr Res. 1999;8:39&#x02013;48.</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Lochner</surname><given-names>C</given-names></name><name><surname>Mar&#x000e9;</surname><given-names>KT</given-names></name><name><surname>Stein</surname><given-names>DJ</given-names></name></person-group><article-title>Structured clinical interview for diagnosing obsessive-compulsive spectrum disorders</article-title><source>Compr Psychiatry</source><year>2024</year><volume>133</volume><fpage>152494</fpage><?supplied-pmid 38718482?><pub-id pub-id-type="pmid">38718482</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Lochner C, Mar&#x000e9; KT, Stein DJ. Structured clinical interview for diagnosing obsessive-compulsive spectrum disorders. Compr Psychiatry. 2024;133: 152494.<pub-id pub-id-type="pmid">38718482</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Hollander</surname><given-names>E</given-names></name><name><surname>Kwon</surname><given-names>JH</given-names></name><name><surname>Stein</surname><given-names>DJ</given-names></name><name><surname>Broatch</surname><given-names>J</given-names></name><name><surname>Rowland</surname><given-names>CT</given-names></name><name><surname>Himelein</surname><given-names>CA</given-names></name></person-group><article-title>Obsessive-compulsive and spectrum disorders: overview and quality of life issues</article-title><source>J Clin Psychiatry</source><year>1996</year><volume>57</volume><issue>Suppl 8</issue><fpage>3</fpage><lpage>6</lpage><?supplied-pmid 8698678?><pub-id pub-id-type="pmid">8698678</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Hollander E, Kwon JH, Stein DJ, Broatch J, Rowland CT, Himelein CA. Obsessive-compulsive and spectrum disorders: overview and quality of life issues. J Clin Psychiatry. 1996;57(Suppl 8):3&#x02013;6.<pub-id pub-id-type="pmid">8698678</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>RC</given-names></name><name><surname>Merikangas</surname><given-names>KR</given-names></name><name><surname>Berglund</surname><given-names>P</given-names></name><name><surname>Eaton</surname><given-names>WW</given-names></name><name><surname>Koretz</surname><given-names>DS</given-names></name><name><surname>Walters</surname><given-names>EE</given-names></name></person-group><article-title>Mild disorders should not be eliminated from the DSM-V</article-title><source>Arch Gen Psychiatry</source><year>2003</year><volume>60</volume><fpage>1117</fpage><lpage>1122</lpage><?supplied-pmid 14609887?><pub-id pub-id-type="pmid">14609887</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Kessler RC, Merikangas KR, Berglund P, Eaton WW, Koretz DS, Walters EE. Mild disorders should not be eliminated from the DSM-V. Arch Gen Psychiatry. 2003;60:1117&#x02013;22.<pub-id pub-id-type="pmid">14609887</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Ruscio</surname><given-names>AM</given-names></name></person-group><article-title>Normal versus pathological mood: implications for diagnosis</article-title><source>Annu Rev Clin Psychol</source><year>2019</year><volume>15</volume><fpage>179</fpage><lpage>205</lpage><?supplied-pmid 31067413?><pub-id pub-id-type="pmid">31067413</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Ruscio AM. Normal versus pathological mood: implications for diagnosis. Annu Rev Clin Psychol. 2019;15:179&#x02013;205.<pub-id pub-id-type="pmid">31067413</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000fc;ckers</surname><given-names>ML</given-names></name><name><surname>Brewin</surname><given-names>CR</given-names></name></person-group><article-title>A paradox in individual versus national mental health vulnerability: are higher resource levels associated with higher disorder prevalence?</article-title><source>J Trauma Stress</source><year>2016</year><volume>29</volume><fpage>572</fpage><lpage>576</lpage><?supplied-pmid 27859656?><pub-id pub-id-type="pmid">27859656</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">D&#x000fc;ckers ML, Brewin CR. A paradox in individual versus national mental health vulnerability: are higher resource levels associated with higher disorder prevalence? J Trauma Stress. 2016;29:572&#x02013;6.<pub-id pub-id-type="pmid">27859656</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="other">Scott KM, Stein DJ, de Jonge P, Kessler RC. Discussion. In: Mental disorders around the world: Facts and figures from the WHO World Mental Health surveys. 2017. Cambridge University Press: New York, NY.</mixed-citation></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>KA</given-names></name><name><surname>Swedo</surname><given-names>SE</given-names></name></person-group><article-title>Post-infectious autoimmune disorders: Sydenham's chorea</article-title><source>PANDAS and beyond Brain Res</source><year>2015</year><volume>1617</volume><fpage>144</fpage><lpage>154</lpage><?supplied-pmid 25301689?><pub-id pub-id-type="pmid">25301689</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Williams KA, Swedo SE. Post-infectious autoimmune disorders: Sydenham&#x02019;s chorea. PANDAS and beyond Brain Res. 2015;1617:144&#x02013;54.<pub-id pub-id-type="pmid">25301689</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Padma</surname><given-names>TV</given-names></name></person-group><article-title>Developing countries: the outcomes paradox</article-title><source>Nature</source><year>2014</year><volume>508</volume><issue>7494</issue><fpage>S14</fpage><lpage>S15</lpage><?supplied-pmid 24695329?><pub-id pub-id-type="pmid">24695329</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Padma TV. Developing countries: the outcomes paradox. Nature. 2014;508(7494):S14&#x02013;5.<pub-id pub-id-type="pmid">24695329</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Brander</surname><given-names>G</given-names></name><name><surname>P&#x000e9;rez-Vigil</surname><given-names>A</given-names></name><name><surname>Larsson</surname><given-names>H</given-names></name><name><surname>Mataix-Cols</surname><given-names>D</given-names></name></person-group><article-title>Systematic review of environmental risk factors for obsessive-compulsive disorder: a proposed roadmap from association to causation</article-title><source>Neurosci Biobehav Rev</source><year>2016</year><volume>65</volume><fpage>36</fpage><lpage>62</lpage><?supplied-pmid 27013116?><pub-id pub-id-type="pmid">27013116</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Brander G, P&#x000e9;rez-Vigil A, Larsson H, Mataix-Cols D. Systematic review of environmental risk factors for obsessive-compulsive disorder: a proposed roadmap from association to causation. Neurosci Biobehav Rev. 2016;65:36&#x02013;62.<pub-id pub-id-type="pmid">27013116</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Fullana</surname><given-names>MA</given-names></name><name><surname>Tortella-Feliu</surname><given-names>M</given-names></name><name><surname>Fern&#x000e1;ndez de la Cruz</surname><given-names>L</given-names></name><name><surname>Chamorro</surname><given-names>J</given-names></name><name><surname>P&#x000e9;rez-Vigil</surname><given-names>A</given-names></name><name><surname>Ioannidis</surname><given-names>JPA</given-names></name><etal/></person-group><article-title>Risk and protective factors for anxiety and obsessive-compulsive disorders: an umbrella review of systematic reviews and meta-analyses</article-title><source>Psychol Med.</source><year>2020</year><volume>50</volume><fpage>1300</fpage><lpage>15</lpage><?supplied-pmid 31172897?><pub-id pub-id-type="pmid">31172897</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Fullana MA, Tortella-Feliu M, Fern&#x000e1;ndez de la Cruz L, Chamorro J, P&#x000e9;rez-Vigil A, Ioannidis JPA, et al. Risk and protective factors for anxiety and obsessive-compulsive disorders: an umbrella review of systematic reviews and meta-analyses. Psychol Med. 2020;50:1300&#x02013;15.<pub-id pub-id-type="pmid">31172897</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="other">Williams M, Chapman L, Simms J, Tellawi G. Cross&#x02010;cultural phenomenology of obsessive&#x02010;compulsive disorder. In: The Wiley handbook of obsessive compulsive disorders. Washington: 2017. John Wiley &#x00026; Sons Ltd.; p. 56&#x02013;74.</mixed-citation></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Fineberg</surname><given-names>NA</given-names></name><name><surname>Dell'Osso</surname><given-names>B</given-names></name><name><surname>Albert</surname><given-names>U</given-names></name><name><surname>Maina</surname><given-names>G</given-names></name><name><surname>Geller</surname><given-names>D</given-names></name><name><surname>Carmi</surname><given-names>L</given-names></name><etal/></person-group><article-title>Early intervention for obsessive compulsive disorder: an expert consensus statement</article-title><source>Eur Neuropsychopharmacol</source><year>2019</year><volume>29</volume><fpage>549</fpage><lpage>565</lpage><?supplied-pmid 30773387?><pub-id pub-id-type="pmid">30773387</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Fineberg NA, Dell&#x02019;Osso B, Albert U, Maina G, Geller D, Carmi L, et al. Early intervention for obsessive compulsive disorder: an expert consensus statement. Eur Neuropsychopharmacol. 2019;29:549&#x02013;65.<pub-id pub-id-type="pmid">30773387</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Leckman</surname><given-names>JF</given-names></name><name><surname>Denys</surname><given-names>D</given-names></name><name><surname>Simpson</surname><given-names>HB</given-names></name><name><surname>Mataix-Cols</surname><given-names>D</given-names></name><name><surname>Hollander</surname><given-names>E</given-names></name><name><surname>Saxena</surname><given-names>S</given-names></name><etal/></person-group><article-title>Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V</article-title><source>Depress Anxiety</source><year>2010</year><volume>27</volume><fpage>507</fpage><lpage>527</lpage><?supplied-pmid 20217853?><pub-id pub-id-type="pmid">20217853</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Leckman JF, Denys D, Simpson HB, Mataix-Cols D, Hollander E, Saxena S, et al. Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depress Anxiety. 2010;27:507&#x02013;27.<pub-id pub-id-type="pmid">20217853</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Viana</surname><given-names>MC</given-names></name><name><surname>Kazdin</surname><given-names>AE</given-names></name><name><surname>Harris</surname><given-names>MG</given-names></name><name><surname>Stein</surname><given-names>DJ</given-names></name><name><surname>Vigo</surname><given-names>DV</given-names></name><name><surname>Hwang</surname><given-names>I</given-names></name><etal/></person-group><article-title>Barriers to 12-month treatment of common anxiety, mood, and substance use disorders in the World Mental Health (WMH) surveys</article-title><source>Int J Ment Health Syst</source><year>2025</year><volume>19</volume><fpage>6</fpage><?supplied-pmid 39924481?><pub-id pub-id-type="pmid">39924481</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Viana MC, Kazdin AE, Harris MG, Stein DJ, Vigo DV, Hwang I, et al. Barriers to 12-month treatment of common anxiety, mood, and substance use disorders in the World Mental Health (WMH) surveys. Int J Ment Health Syst. 2025;19:6.<pub-id pub-id-type="pmid">39924481</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Vigo</surname><given-names>DV</given-names></name><name><surname>Stein</surname><given-names>DJ</given-names></name><name><surname>Harris</surname><given-names>MG</given-names></name><name><surname>Kazdin</surname><given-names>AE</given-names></name><name><surname>Viana</surname><given-names>MC</given-names></name><name><surname>Munthali</surname><given-names>R</given-names></name><etal/></person-group><article-title>Effective treatment for mental and substance use disorders in 21 countries</article-title><source>JAMA Psychiat</source><year>2025</year><volume>82</volume><fpage>347</fpage><lpage>357</lpage></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Vigo DV, Stein DJ, Harris MG, Kazdin AE, Viana MC, Munthali R, et al. Effective treatment for mental and substance use disorders in 21 countries. JAMA Psychiat. 2025;82:347&#x02013;57.</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Brakoulias</surname><given-names>V</given-names></name><name><surname>Starcevic</surname><given-names>V</given-names></name><name><surname>Belloch</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>C</given-names></name><name><surname>Ferrao</surname><given-names>YA</given-names></name><name><surname>Fontenelle</surname><given-names>LF</given-names></name><etal/></person-group><article-title>Comorbidity, age of onset and suicidality in obsessive-compulsive disorder (OCD): an international collaboration</article-title><source>Compr Psychiatry</source><year>2017</year><volume>76</volume><fpage>79</fpage><lpage>86</lpage><?supplied-pmid 28433854?><pub-id pub-id-type="pmid">28433854</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Brakoulias V, Starcevic V, Belloch A, Brown C, Ferrao YA, Fontenelle LF, et al. Comorbidity, age of onset and suicidality in obsessive-compulsive disorder (OCD): an international collaboration. Compr Psychiatry. 2017;76:79&#x02013;86.<pub-id pub-id-type="pmid">28433854</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>DJ</given-names></name><name><surname>Craske</surname><given-names>MG</given-names></name><name><surname>Rothbaum</surname><given-names>BO</given-names></name><name><surname>Chamberlain</surname><given-names>SR</given-names></name><name><surname>Fineberg</surname><given-names>NA</given-names></name><name><surname>Choi</surname><given-names>KW</given-names></name><etal/></person-group><article-title>The clinical characterization of the adult patient with an anxiety or related disorder aimed at personalization of management</article-title><source>World Psychiatry</source><year>2021</year><volume>20</volume><fpage>336</fpage><lpage>356</lpage><?supplied-pmid 34505377?><pub-id pub-id-type="pmid">34505377</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Stein DJ, Craske MG, Rothbaum BO, Chamberlain SR, Fineberg NA, Choi KW, et al. The clinical characterization of the adult patient with an anxiety or related disorder aimed at personalization of management. World Psychiatry. 2021;20:336&#x02013;56.<pub-id pub-id-type="pmid">34505377</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Randazza</surname><given-names>MP</given-names></name><name><surname>McKay</surname><given-names>D</given-names></name><name><surname>Bakhshaie</surname><given-names>J</given-names></name><name><surname>Storch</surname><given-names>EA</given-names></name><name><surname>Zvolensky</surname><given-names>MJ</given-names></name></person-group><article-title>Unhealthy alcohol use associated with obsessive-compulsive symptoms: the moderating effects of anxiety and depression</article-title><source>J Obsessive Compuls Relat Disord</source><year>2022</year><volume>32</volume><fpage>100713</fpage><?supplied-pmid 35242506?><pub-id pub-id-type="pmid">35242506</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Randazza MP, McKay D, Bakhshaie J, Storch EA, Zvolensky MJ. Unhealthy alcohol use associated with obsessive-compulsive symptoms: the moderating effects of anxiety and depression. J Obsessive Compuls Relat Disord. 2022;32: 100713.<pub-id pub-id-type="pmid">35242506</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Virtanen</surname><given-names>S</given-names></name><name><surname>Kuja-Halkola</surname><given-names>R</given-names></name><name><surname>Sidorchuk</surname><given-names>A</given-names></name><name><surname>Fern&#x000e1;ndez de la Cruz</surname><given-names>L</given-names></name><name><surname>R&#x000fc;ck</surname><given-names>C</given-names></name><name><surname>Lundstr&#x000f6;m</surname><given-names>S</given-names></name><etal/></person-group><article-title>Association of obsessive-compulsive disorder and obsessive-compulsive symptoms with substance misuse in 2 longitudinal cohorts in Sweden</article-title><source>JAMA Netw Open.</source><year>2022</year><volume>5</volume><fpage>e2214779</fpage><?supplied-pmid 35666504?><pub-id pub-id-type="pmid">35666504</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Virtanen S, Kuja-Halkola R, Sidorchuk A, Fern&#x000e1;ndez de la Cruz L, R&#x000fc;ck C, Lundstr&#x000f6;m S, et al. Association of obsessive-compulsive disorder and obsessive-compulsive symptoms with substance misuse in 2 longitudinal cohorts in Sweden. JAMA Netw Open. 2022;5:e2214779.<pub-id pub-id-type="pmid">35666504</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Horenstein</surname><given-names>A</given-names></name><name><surname>Heimberg</surname><given-names>RG</given-names></name></person-group><article-title>Anxiety disorders and healthcare utilization: a systematic review</article-title><source>Clin Psychol Rev</source><year>2020</year><volume>81</volume><fpage>101894</fpage><?supplied-pmid 32818687?><pub-id pub-id-type="pmid">32818687</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Horenstein A, Heimberg RG. Anxiety disorders and healthcare utilization: a systematic review. Clin Psychol Rev. 2020;81: 101894.<pub-id pub-id-type="pmid">32818687</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Endrass</surname><given-names>T</given-names></name><name><surname>Riesel</surname><given-names>A</given-names></name><name><surname>Kathmann</surname><given-names>N</given-names></name><name><surname>Buhlmann</surname><given-names>U</given-names></name></person-group><article-title>Performance monitoring in obsessive-compulsive disorder and social anxiety disorder</article-title><source>J Abnorm Psychol</source><year>2014</year><volume>123</volume><issue>4</issue><fpage>705</fpage><lpage>714</lpage><?supplied-pmid 25286372?><pub-id pub-id-type="pmid">25286372</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Endrass T, Riesel A, Kathmann N, Buhlmann U. Performance monitoring in obsessive-compulsive disorder and social anxiety disorder. J Abnorm Psychol. 2014;123(4):705&#x02013;14.<pub-id pub-id-type="pmid">25286372</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Hofer</surname><given-names>PD</given-names></name><name><surname>Wahl</surname><given-names>K</given-names></name><name><surname>Meyer</surname><given-names>AH</given-names></name><name><surname>Mich&#x000e9;</surname><given-names>M</given-names></name><name><surname>Beesdo-Baum</surname><given-names>K</given-names></name><name><surname>Wittchen</surname><given-names>H-U</given-names></name><etal/></person-group><article-title>The role of behavioral inhibition, perceived parental rearing, and adverse life events in adolescents and young adults with incident obsessive-compulsive disorder</article-title><source>J Obsessive Compuls Relat Disord</source><year>2018</year><volume>19</volume><fpage>116</fpage><lpage>123</lpage></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Hofer PD, Wahl K, Meyer AH, Mich&#x000e9; M, Beesdo-Baum K, Wittchen H-U, et al. The role of behavioral inhibition, perceived parental rearing, and adverse life events in adolescents and young adults with incident obsessive-compulsive disorder. J Obsessive Compuls Relat Disord. 2018;19:116&#x02013;23.</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Grisham</surname><given-names>JR</given-names></name><name><surname>Fullana</surname><given-names>MA</given-names></name><name><surname>Mataix-Cols</surname><given-names>D</given-names></name><name><surname>Moffitt</surname><given-names>TE</given-names></name><name><surname>Caspi</surname><given-names>A</given-names></name><name><surname>Poulton</surname><given-names>R</given-names></name></person-group><article-title>Risk factors prospectively associated with adult obsessive-compulsive symptom dimensions and obsessive-compulsive disorder</article-title><source>Psychol Med</source><year>2011</year><volume>41</volume><fpage>2495</fpage><lpage>2506</lpage><?supplied-pmid 21672296?><pub-id pub-id-type="pmid">21672296</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Grisham JR, Fullana MA, Mataix-Cols D, Moffitt TE, Caspi A, Poulton R. Risk factors prospectively associated with adult obsessive-compulsive symptom dimensions and obsessive-compulsive disorder. Psychol Med. 2011;41:2495&#x02013;506.<pub-id pub-id-type="pmid">21672296</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>HB</given-names></name><name><surname>van den Heuvel</surname><given-names>OA</given-names></name><name><surname>Miguel</surname><given-names>EC</given-names></name><name><surname>Reddy</surname><given-names>YCJ</given-names></name><name><surname>Stein</surname><given-names>DJ</given-names></name><name><surname>Lewis-Fern&#x000e1;ndez</surname><given-names>R</given-names></name><etal/></person-group><article-title>Toward identifying reproducible brain signatures of obsessive-compulsive profiles: rationale and methods for a new global initiative</article-title><source>BMC Psychiatry</source><year>2020</year><volume>20</volume><fpage>68</fpage><?supplied-pmid 32059696?><pub-id pub-id-type="pmid">32059696</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Simpson HB, van den Heuvel OA, Miguel EC, Reddy YCJ, Stein DJ, Lewis-Fern&#x000e1;ndez R, et al. Toward identifying reproducible brain signatures of obsessive-compulsive profiles: rationale and methods for a new global initiative. BMC Psychiatry. 2020;20:68.<pub-id pub-id-type="pmid">32059696</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>DJ</given-names></name></person-group><article-title>Obsessive-compulsive disorder and global mental health</article-title><source>Indian J Psychiatry</source><year>2019</year><volume>61</volume><issue>Suppl 1</issue><fpage>S4</fpage><lpage>S8</lpage><?supplied-pmid 30745672?><pub-id pub-id-type="pmid">30745672</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Stein DJ. Obsessive-compulsive disorder and global mental health. Indian J Psychiatry. 2019;61(Suppl 1):S4&#x02013;8.<pub-id pub-id-type="pmid">30745672</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>DJ</given-names></name><name><surname>Kogan</surname><given-names>CS</given-names></name><name><surname>Atmaca</surname><given-names>M</given-names></name><name><surname>Fineberg</surname><given-names>NA</given-names></name><name><surname>Fontenelle</surname><given-names>LF</given-names></name><name><surname>Grant</surname><given-names>JE</given-names></name><etal/></person-group><article-title>The classification of obsessive-compulsive and related disorders in the ICD-11</article-title><source>J Affect Disord</source><year>2016</year><volume>190</volume><fpage>663</fpage><lpage>674</lpage><?supplied-pmid 26590514?><pub-id pub-id-type="pmid">26590514</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Stein DJ, Kogan CS, Atmaca M, Fineberg NA, Fontenelle LF, Grant JE, et al. The classification of obsessive-compulsive and related disorders in the ICD-11. J Affect Disord. 2016;190:663&#x02013;74.<pub-id pub-id-type="pmid">26590514</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>van den Heuvel</surname><given-names>OA</given-names></name><name><surname>Boedhoe</surname><given-names>PSW</given-names></name><name><surname>Bertolin</surname><given-names>S</given-names></name><name><surname>Bruin</surname><given-names>WB</given-names></name><name><surname>Francks</surname><given-names>C</given-names></name><name><surname>Ivanov</surname><given-names>I</given-names></name><etal/></person-group><article-title>An overview of the first 5 years of the ENIGMA obsessive-compulsive disorder working group: the power of worldwide collaboration</article-title><source>Hum Brain Mapp</source><year>2022</year><volume>43</volume><fpage>23</fpage><lpage>36</lpage><?supplied-pmid 32154629?><pub-id pub-id-type="pmid">32154629</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">van den Heuvel OA, Boedhoe PSW, Bertolin S, Bruin WB, Francks C, Ivanov I, et al. An overview of the first 5 years of the ENIGMA obsessive-compulsive disorder working group: the power of worldwide collaboration. Hum Brain Mapp. 2022;43:23&#x02013;36.<pub-id pub-id-type="pmid">32154629</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><mixed-citation publication-type="other">Kessler RC. National Comorbidity Survey (NCS) <ext-link ext-link-type="uri" xlink:href="https://www.icpsr.umich.edu/web/ICPSR/series/00527">https://www.icpsr.umich.edu/web/ICPSR/series/00527</ext-link>. National Comorbidity Survey: Baseline (NCS-1), 2008, 10.3886/ICPSR06693.v6.</mixed-citation></ref></ref-list></back></article>